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ABSTRACT OF THE DISSERTATION
ANTIBACTERIAL PROTEINS AND PEPTIDES IN NURSE SHARK (GINGLYMOSTOMA
CIRRATUM) PERIPHERAL BLOOD LEUKOCYTES
by
Nichole Hinds Vaughan
Florida International University, 2011
Miami, Florida
Professor Charles H. Bigger, Major Professor
In many vertebrate and invertebrate species mediators of innate immunity
include antimicrobial peptides (AMPs) such as peptide fragments of histones and other
proteins with previously ascribed different functions.

Shark AMPs have not been

described and this research examines the antibacterial activity of nurse shark
(Ginglymostoma cirratum) peripheral blood leukocyte lysates. Screening of lysates
prepared by homogenizing unstimulated peripheral blood leukocytes identified
muramidase (lysozyme‐like) and non‐muramidase antibacterial activity. Lysates were
tested for lysozyme using the lysoplate assays, and antibacterial (AB) activity was
assayed for by a microdilution growth assay that was developed using Planococcus
citreus as the target bacterium. Fractionation of crude lysates by ion exchange and
affinity chromatography was followed by a combination of SDS‐PAGE with LC/MS‐MS
and/or N‐terminal sequence analysis of low molecular weight protein bands (<20 kDa).
This yielded several peptides with amino acid sequence similarity to lysozyme, ubiquitin,
hemoglobin, human histones H2A, H2B and H4 and to antibacterial histone fragments of
vi

the catfish and the Asian toad. Not all peptide sequences corresponded to peptides
potentially antibacterial. The correlation of a specific protein band in active lysate
fractions was accomplished by employing the acid‐urea gel overlay assays in which AB
activity was seen as zones of growth inhibition on a lawn of P. citreus at a position
corresponding to that of the putative AB protein band. This study is the first to describe
putative AMPs in the shark and their potential role in innate immunity.
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I. INTRODUCTION

The mammalian immune system is a complex network of cells, organs, tissue, and
soluble protein substances that interact to protect the body from foreign materials,
recognized as non‐self. This protection can take the form of an adaptive, targeted
response or an innate and immediate response. Immune cells will surveil, and detect,
non‐native molecules and either mount an attack or call in reinforcements, or both
(Klein 1997).
The innate immune system is comprised of several components: (1) physical and
chemical barriers such as the skin, the low pH of the stomach, and the sweeping motion
of the cilia in the airway; (2) cellular and (3) humoral factors. The cellular components
consist of a variety of different cell types that include macrophage/monocytes,
granulocytes such as neutrophils, basophils and eosinophils, mast cells, dendritic cells
and natural killer cells and can function by direct intervention through either
engulfment of the foreign particle or by indirect interaction when stimulated through
subsequent secretion of soluble proteins (Kindt et al. 2007). Humoral factors include
soluble proteins such as complement proteins, hydrolyzing enzymes, cytokines and the
ubiquitous antimicrobial peptides (Kindt et al. 2007). Antimicrobial peptides, key
mediators of innate immune function, have emerged as effective defense molecules,
patrolling host borders, fighting off and killing invading pathogens, and acting as the first
line of defense.
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Antimicrobial peptides, which have recently been renamed as host defense peptides
(Steinstraesser et al. 2009), play a significant role in angiogenesis (Huang et al. 1997; Li
et al. 2000), chemotaxis (Fleischmann et al. 1985; Ichinose et al. 1996), cytokine
production (Chaly et al. 2000), histamine release (Befus et al. 1999; Niyonsaba et al.
2001), lipopolysaccharide (LPS)‐binding (Nagaoka et al. 2001; Nagaoka et al. 2002) and
other immunomodulatory activities (Yang et al. 2002; Bals et al. 2003; Bowdish et al.
2005). However, the main function of antimicrobial peptides is to kill microbes.
Collectively, these peptides exhibit a broad spectrum of activity against microbes,
including gram positive and gram negative bacteria, fungi, mycoplasma, and viruses
(reviewed in Boman, 1998).
Antimicrobial peptides have been isolated from a wide variety of animals. They are
present in several vertebrates including mammals (Selsted et al. 1985; Zanetti et al.
1995), birds (Harwig et al. 1994; Sugiarto et al. 2004), amphibians (Zasloff 1987) and
teleost fish, (Cole et al. 1997; Noga et al. 2003) and in invertebrates, such as insects
(Boman et al. 1985; Casteels et al. 1989; Moore et al. 1996), horse‐shoe crabs (Schnapp
et al. 1996; Relf et al. 1999), tunicates (Lee et al. 1997) and shrimp (Destoumieux et al.
1997). They have also been documented in plants (Rinehart et al. 1990; Harrison et al.
1999; Stephens et al. 2005) and bacteria (Boman 1998, 2003; Sang et al. 2008).
To date, little is known of antimicrobial peptides in elasmobranchs, including sharks,
although antimicrobial proteins such as transferrin (Davies et al. 1987) and squalamine,
an aminosterol (Moore et al. 1993), have been identified in the dogfish shark. A cationic
antimicrobial peptide has been described for the fermented skate, Raja kenojei, from
2

skin extracts (Cho et al. 2005). There have also been some functional studies conducted
on lysozyme‐like activity using nurse shark serum (Hedayati 1992). There are many
generalities shared by this class of vertebrates. Each species, however, must be
examined on its own merit. Rays, sharks and other elasmobranchs display many
differences in habitat, behavior and physiology. Even sharks within the same
subdivision differ in some features as fundamental as the function of hematopoietic
organs (Fange 1977), therefore It is unwise to use one species of sharks to wholly
represent other species.
Most investigators studying the immune system of the shark focus on adaptive
immune mechanisms (Greenberg et al. 1995; Ohta et al. 2002; Rumfelt et al. 2002;
Dooley et al. 2005; Haines et al. 2005; Zhang et al. 2006; Flajnik et al. 2009). Research is
also being conducted on innate immune mechanisms of the shark, particularly the
complement system and the role and function of circulating leukocytes (Smith et al.
1989; Dodds et al. 1998; Merly et al. 2007; Shin et al. 2007; Aybar et al. 2009; Graham et
al. 2009; Shin et al. 2009). The composition of shark peripheral blood differs from
humans in several ways (Hyder et al. 1983). Firstly, shark serum contains relatively high
concentrations of salt (0.25 M) and urea (0.35 M) and its complement proteins have
certain unique features. In addition, the bulk protein in serum is not albumin, as is seen
in most mammals, but rather immunoglobulin (natural antibody) which can amount to
as much as 40% of total serum protein. Secondly, the cellular components of shark
blood also show differences. Curiously, there has not been a published histological
study using light microscopy, of nurse shark (the shark used in this study) peripheral
3

blood leukocytes. However, some general cellular characteristics prevail. Unlike the
non‐nucleated discoidal human erythrocytes, shark mature erythrocytes are nucleated
ellipsoidal structures. Shark granulocytic leukocytes morphologically resemble
mammalian neutrophils and eosinophils, and the mononuclear cells are similar to
lymphocytes and monocyte/macrophages. The shark granulocytes and
monocyte/macrophages have been shown to be phagocytic and chemotactic cells
(Hyder et al. 1983; Obenauf et al. 1985). In addition, shark blood contains the
thrombocyte, a cell absent from mammalian peripheral blood. Thrombocytes are
believed to play a role in coagulation, similar to that of human platelets which the shark
lacks. The shark lacks bone marrow (its skeleton is composed of cartilage) and it is not
unusual to find immature undifferentiated cells circulating in peripheral blood (Hyder et
al. 1983).
Antimicrobial peptides can be produced by a variety of cell types such as:
hemocytes of the crab (Schnapp et al. 1996), cecropia moth (Steiner et al. 1981) and
pacific shrimp (Patat et al. 2004), mammalian paneth cells (Mallow et al. 1996),
epithelial cells (Diamond et al. 1991), and neutrophils (Befus et al. 1999); and skin
mucosa of fish (Cho et al. 2002) and frogs (Zasloff 1987). To date, no investigation has
been undertaken to investigate the antimicrobial proteins and/or peptides associated
with circulating leukocytes in the nurse shark.
The major objective of this research is the identification and characterization of
antibacterial activity of nurse shark, Ginglymostoma cirratum, peripheral blood
leukocytes. Peripheral blood leukocytes were chosen as the cell population to study
4

since circulating leukocytes in other vertebrate species play an important role in the
initial line of defense and are known to secrete a variety of antimicrobial peptides
(Spitznagel 1984, 1990). Earlier studies showed two distinctly different types of
antimicrobial activity associated with shark peripheral leukocytes: a lysozyme‐like
activity and a non‐lysozyme‐like antibacterial activity (Hinds et al. 2001).
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II. BACKGROUND

In plants and animals, gene‐encoded antimicrobial peptides are rapidly expressed
and delivered directly to sites of microbial infiltration (Boman 1998, 2003). This rapid
response, though non‐specific, differs from the clonally based adaptive immune
response (Burnet 1957), which is an acquired response to stimuli.
Intracellular Immune Factors
When combating an infection, the mammalian innate immune system is called upon
to mount an immediate response to invading pathogenic microbes. With generation
times of 20‐30 min (Boman 1995), this response, once thought to be ‘non‐specific’, can
immediately mobilize phagocytic and cytotoxic cells like macrophages, neutrophils, T‐
cells and Natural killer (NK) cells to release signaling molecules such as interleukins (IL‐1,
IL‐2) and tumor necrosis factor‐alpha (TNF‐α) (Klein 1997) and other effector molecules
such as lectins (Feizi 2000), NK‐lysin (Andersson et al. 1995) or nitric oxide (Fang 1997).
The quick response differs from the acquired immune response, which because of its
incredible specificity, may take days and even weeks for the clonal expansion of T and B
lymphocytes to target specific antigens (Klein 1997).
The innate immune defense must selectively destroy or inactivate the invading
pathogen, while protecting the structural integrity of the host. In order to do this,
receptor mediated recognition of common molecular features differentiating host cells
from foreign cells, is necessary. These pathogen‐associated molecular patterns
(PAMPs) can take the form, for example, of surface associated glycans, formylated
6

peptides, lipopolysaccharide, CpG DNA and coat proteins of viruses (Brown 2001;
Girardin et al. 2002). The pattern recognition results in the delivery of effector
molecules to the site of infection, such as complement activation on the microbial
surface, or antigen/pathogen ingestion followed by the release of reactive oxygen
products and granule contents into phagocytic vacuoles (Ganz et al. 1997). These
defense mechanisms can inhibit the entry of the microbe, disruption of crucial
microbial structures, sequestration of essential nutrients for microbial survival,
interference with microbial metabolism, or inhibition of microbial multiplication. These
mechanisms utilize inorganic compounds such as hydrogen peroxide, hydrochloric
acid, hypochlorous acid, or organic compounds such as chloramines, fatty acids,
peptides and proteins (Ganz et al. 1997). The molecules that perform these defense
functions (some of which are discussed below) are varied in their physicochemical
characteristics, their mechanism of action and their location.
It is evident that the intracellular components are exceedingly potent and are
crucial to host defense. The phagocytic cells, neutrophils, monocytes and
macrophages play a significant role in immune function, monitoring the body for any
invading agent. Once stimulated, these phagocytes possess an impressive arsenal that
includes production of bactericidal‐reactive oxygen compounds, release of the
contents of cytoplasmic granules into the phagosome or the exterior, secretion of
cytokine and other regulatory intermediates (thereby attracting other cells to the site
of infection), crossing the blood vessel endothelia, with active movement through
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tissue towards source of infection, and production of bactericidal nitric oxide and its
derivatives (Klein 1997).
Antimicrobial Proteins
There are several proteins that are associated with the non‐oxidative response in
mammalian phagocytic cells that are antimicrobial in nature, one of which is cathepsin
G, a serine protease that is found in the azurophilic granules of neutrophils, and some
monocytes (Odeberg et al. 1975; Senior et al. 1982; Spitznagel 1990; Kudo et al. 2009).
Cathepsin G is a 26 kDa neutral enzyme that is released by activated neutrophils in
humans, and plays an important role in inflammation through the hydrolysis of many
different proteins, including extracellular matrix and some chemo‐attractants such as
TNF‐α and IL‐8 (Wiedow et al. 2005).
Phospholipase A2 selectively hydrolyzes phospholipids in bacterial membranes,
and is a member of a large family of ‘secretory’ phospholipases that are produced by
vertebrates and invertebrates (Dennis 1997). The family of phospholipase A2 shares
several highly conserved features, including size (14‐16 kDa), high disulfide bond
content, a Ca2+‐binding loop, and closely similar catalytic machinery and secondary and
tertiary structure (Dennis 1997; Ganz et al. 1997). Bactericidal/permeability‐increasing
protein, BPI, is a highly cationic protein known for its potent and selective cytotoxic
activity toward gram‐negative bacteria and its high affinity for LPS (Elsbach et al.
1993).
Transferrins are non‐heme, globular, iron‐binding glycoproteins, found in the
serum of most vertebrates; they are also present in avian egg white and in mammalian
8

milk (Putnam 1975; Ingram 1980). Human transferrin has an approximate molecular
weight of 80‐90 kDa and displays bacteriostatic activity when not fully saturated with
iron. Its role when confronting a bacterial infection consists of chelating any free
available iron present, making it unavailable to the invading organism (Weinberg 1974;
Ingram 1980). Lactoferrin, a member of the transferrin family, is a high affinity iron‐
chelator in milk, and also displays bacteriostatic properties (Bullen et al. 1979; Ellison
et al. 1991; Bellamy et al. 1993). Lactoferrin has been found to contain an
antimicrobial sequence near its N‐terminus which appears to function by a mechanism
distinct from iron chelation (Tomita et al 1994). Antimicrobial peptides representing
this bactericidal domain of lactoferrin were isolated following pepsin cleavage of
human lactoferrin and bovine lactoferrin. The resultant antimicrobial peptide was
termed lactoferricin, and has been shown to have potent broad spectrum, lethal
antimicrobial properties, causing a rapid loss of colony‐forming capability (Tomita et
al. 1994). The antimicrobial activity of lactoferrin is often linked with lysozyme (Ellison
et al. 1991). In humans both these enzymes are found in polymorphonuclear
leukocytes (PMN), i.e., neutrophils, and are also present in high concentration in
human mucosal secretions (Masson et al. 1966; Bullen et al. 1979; Ellison et al. 1991).
Lysozyme is a basic, cationic protein, and of particular interest because its main
biological function is protection of the host against bacterial infections (Imoto 1972). It
induces bacterial cell lysis by hydrolyzing the ‐1‐4 linked glycosidic bonds of the
peptidoglycan cell wall (Imoto 1972), and is produced mainly by monocytes and
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granulocytic blood cells in mammals (Jolles et al. 1966; Pruzanski et al. 1969). There are
two main types of lysozyme that have been described from birds (Jolles et al. 1984) and
have been termed c‐type (e.g., hen egg white lysozyme) and g‐type (e.g., goose egg
white lysozyme). These two main types of lysozyme differ slightly in their amino acid
sequence and molecular weight. The G‐Type lysozyme has low cysteine and tryptophan
content and has a higher molecular weight of 21 kDa than the c‐type lysozyme (14 kDa)
(Jolles et al. 1984). Other lysozymes have been discovered, and they differ in primary
structure, physicochemical and immunological criteria (Jolles 1969; Jolles et al. 1984;
Jolles 1996). These other types of lysozyme have been found in bacteria,
bacteriophages, plants, the invertebrate sea star, Asterias rubens, and some teleosts
(Tsugita et al. 1968; Jolles et al. 1975; Fange 1976). There has been lysozyme‐like activity
detected in an elasmobranch, using nurse shark serum, however, this activity was not
studied in detail (Hedayati 1992). Lysozymes differ in amino acid sequence, molecular
weight and enzymatic properties. However, amino acid sequence homology remains in
the specificity of the active site responsible for the hydrolysis of the ‐1‐4 linkage
between N‐acetylmuramic acid and N‐acetylglucosamine (Jolles et al. 1975).
Lysozyme has also been shown to inhibit chemotaxis of activated leukocytes
(Ogundele 1998). Another anti‐inflammatory function includes the inhibition of
mitogen‐induced lymphoblastogenesis (Gordon et al. 1979; Ogundele 1998).
Lysozyme has been found to have an indirect effect on the complement system by
inhibiting the PMN response towards complement‐derived chemotaxins such as
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anaphylatoxins C5a, C3a and C4a (Ogundele 1998). It has been reported to inhibit the
classical pathway of serum complement activity in a reaction that is dose‐dependent
(Ogundele 1998). Its presence as an anti‐inflammatory secretory component serves to
protect the tissues against secondary damage during acute overwhelming infections
(Ogundele 1998). In such situations excessive inflammatory reactions of the
complement system would be undesirable and potentially damaging to host cells.
Another role suggested for lysozyme is the immune surveillance of membranes and
the possibility that it may mediate the antitumor functions of macrophages (Osserman
et al. 1973; Osserman 1976).
Antimicrobial Peptides
There are several classifications for antimicrobials on the basis of their
physicochemical characteristics (reviewed in Boman 1995, 2003). Those over 10 kDa
are generally classified as antibacterial/antimicrobial proteins while those that are
smaller are called peptides. Cathelicidins are members of a large family of peptides, all
of whom share a conserved N‐terminal precursor structure, cathelin, and highly
heterogenous C‐terminal peptides. This family includes human LL37, Bac5 and Bac7,
porcine cathelicidins, and protegrins (Zanetti et al. 1995; Bucki et al. 2010). Some
cathelicidins undergo extracellular proteolytic cleavage that frees the active C‐terminal
peptide from the precursor, while other members of the family appear active in their
original non‐cleaved form (Zanetti et al. 1995). Found in most mammals, LL‐37 is the
only member of the cathelicidin family that is expressed in humans and has shown a
broad spectrum of activity against both gram‐positive and gram‐negative bacteria, as
11

well as various viruses and fungi (Bals et al. 2003; Bucki et al. 2010). It is produced
mainly by leukocytes, epithelial cells and mucosal cells where it is stored in specific
granules (Scott et al. 2002; Steinstraesser et al. 2009). In humans, LL‐37, along with
other cationic peptides, prevent infection at a whole host of body sites, such as in
pulmonary and digestive systems, salivary glands, skin and ocular surfaces, as well as
others (Bucki et al. 2010). LL37 assumes an amphiphatic α‐helical conformation that in
its original state in neutrophils is 17 kDa in size. Once processed to the mature peptide
it is 5 kDa in size, which is why cathelicidins may be categorized as an antimicrobial
protein, as well as a peptide (Boman 1995; Zanetti et al. 1995).
Defensins are a family of closely related, cationic antimicrobial peptides comprised
of 29‐45 amino acid residues. Six conserved cysteine residues are a characteristic
feature of defensins that form three intramolecular disulfide bridges between the
amino and carboxyl terminal regions of the peptide. This creates a cyclic, triple‐
stranded, amphiphatic β‐sheet structure. These three disulfide bridges serve to
stabilize its β‐sheet structure and increase its resistance to proteolysis (Campopiano et
al. 2004; Diamond et al. 2009). Defensins can be divided into α‐ and β‐defensins, which
are very similar in their three dimensional (3D) structure and in function. The
differences between these two groups are (1) the fact that the β‐defensins tend to be
slightly larger, and some may have modified termini, and (2) linkage of the cysteine
residues (Boman 2003). The α‐defensins are produced constitutively and do not seem
to require induction, however, most β‐defensins that have been described are
inducible (Diamond et al. 1991; Boman 2003). The α‐defensins, which have been
12

studied in humans (Selsted et al. 1985), monkeys (Selsted 2004) and rodents (Ayabe et
al. 2000; Ayabe et al. 2004), are found in abundance in neutrophils, macrophages and
paneth cells of the small intestine (Ouellette et al. 1996; Ganz et al. 1998). They seem
to have evolved to work inside the phagosome, where their propeptides are processed
in the granule. These defensins are sequestered in the granules as their natural
cytotoxicity could hurt the host. The β‐defensins have signal peptides but no
propeptides and they seem to be produced by the epithelial cells, protecting the
mucosa both in the lungs and along the digestive tract (Bevins et al. 1999).
Another group that belongs to the defensin family is the θ‐defensin, which are
small, circular molecules, the product of two separate genes; each produces two
separate defensin molecules which are linked covalently (Tang et al. 1999). The θ‐
defensins differ from the α‐ and β‐defensins in that they have a double‐stranded β‐
sheet and have only been found in primates (Tang et al. 1999; Boman 2003).
Magainins belong to a large family of amphibian amphiphatic α‐helical
antimicrobial peptides. They are usually 23 amino acid residues long and were
originally isolated from the African clawed tree frog, Xenopus laevis, following
observations of their continued good health after being surgically altered and left to
recover under non‐sterile conditions (Zasloff 1987). Magainins have been shown to
have a broad spectrum of activity against gram‐negative and gram‐positive bacteria
and fungi, and are known to reduce inflammation and promote wound healing (Zasloff
1987; Zairi et al. 2009). They also possess a potent spermicidal activity against human
sperm, as well as being very effective against sexually transmitted pathogens, making
13

them prime candidates for exploration as spermicides (Zasloff et al. 1988; Reddy et al.
1996).
Antimicrobial peptides are also found in multiple invertebrate animals such as the
penaeid shrimp (Destoumieux et al. 1997; Tassanakajon et al. 2010) and horseshoe
crab (Schnapp et al. 1996). In the penaeid shrimp there are three cationic peptide
families, the penaeidins (Destoumieux et al. 1997), crustins (Relf et al. 1999), and anti‐
lipopolysaccharide factors (ALFs). These peptides are comprised of many different
isoforms and have shown activity against a variety of bacteria and fungi (reviewed in
Tassanakajon et al. 2010). They are synthesized primarily in the hemocytes and are
released in response to infection (Munoz et al. 2002).
Not to be forgotten, plants also produce their own antimicrobial peptides in a wide
range of tissues, and express significant antimicrobial potency (Garcia‐Olmedo et al.
1998). Thionin, the first plant peptide reported to have activity against plant
pathogens, has been shown to alter pathogen cell membrane permeability (Fernandez
de Caleya et al. 1972; Castagnaro et al. 1992). Several families of cysteine‐rich peptides
have been characterized, including defensins, lipid transfer proteins (LTPs), hevein‐
type peptides and knottin‐type peptides (reviewed in Kim et al. 2009), from plants.
Characterization of Antimicrobial Peptides
Boman (1998, 2003) has classified antimicrobial peptides, small amphiphatic
peptides usually between 15 and 45 amino acid residues, on the basis of their
physicochemical characteristics (Boman 1998, 2003). They are further divided into five
subcategories on the basis of their amino acid composition and primary structure:
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(1) anionic peptides, (2) linear amphiphatic α‐helical peptides, (3) cationic peptides
enriched for specific amino acids, (4) peptide fragments, and (5) peptides with
cysteines that form intramolecular bonds (Boman 2000; Brogden 2005; Diamond et al.
2009). Details of the five subcategories are as follows:
1) Anionic peptides. Anionic peptides are present in surfactant extracts,
bronchoalveolar lavage fluid, and airway epithelial cells. They require zinc as a
cofactor for activity and are active against both gram‐positive and gram‐
negative bacteria. Examples include dermcidin in humans and maximin H5
from amphibians (Brogden 2005).
2) Linear amphiphatic α‐helical peptides. This subgroup is the most diverse and
contains about 290 linear cationic α‐helical peptides that tend to be less than
40 amino acid residues in length and possess a three dimensional structure
with a kink or hinge in the middle. These molecules adopt an α‐helical
secondary structure when in contact with membranes, but are disordered in
aqueous solution (Diamond et al. 2009). Examples of these peptides include the
cecropins (Steiner et al. 1981), magainin (Zasloff 1987), pleurocidin from winter
flounder (Cole et al. 1997) and melittin from bee venom (Fennell et al. 1968).
3) Cationic peptides enriched for specific amino acids. This group contains
approximately 44 peptides, all of which are linear in shape and are enriched in
specific amino acids. They lack cysteines residues, which makes them very
flexible and fluid in solution. Examples include the bactenecins and proline‐
arginine‐rich peptide (PR‐39), both of which are rich in proline and arginine;
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proline‐rich abaecin from bees, and indolicidin from cattle, which is rich in
tryptophan (Brogden 2005).
4) Peptide fragments. This fourth group is comprised of charged peptides that are
fragments of larger proteins. For example, lactoferricin (mentioned earlier) is a
peptide derived from the digested N‐terminal portion of lactoferrin (Bellamy et
al. 1993). Similarly, cathelicidins (also mentioned earlier) are peptides which
are found at the C‐terminus of precursors whose N‐termini share a homology
with the porcine serine protease known as cathelin (Zanetti et al. 1995;
Diamond et al. 2009). Also in this group are peptides derived from oxygen‐
binding proteins, such as hemacyanin and hemoglobin derived peptides (Vizioli
et al. 2002).
5) Peptides with intramolecular cysteine bonds. This final group is composed of
roughly 380 members that all contain conserved 6‐cysteine residue motifs
forming intramolecular disulfide bonds and β‐sheets (Brogden 2005). This
defensin group is an extremely diverse group which may have originated in
prokaryotes (Zhu 2007). This group has diverged into plant defensins,
arthropod defensins and the β‐defensins found in birds, reptiles and mammals
(Wong et al. 2007; Diamond et al. 2009; Wong et al. 2009). It includes the θ‐
defensins, which seem to have mutated from the α‐defensins, which in turn
originally diverged from the β‐defensins (Selsted 2004). Similar to the defensins
is a liver‐specific peptide, hepcidin, which is also cysteine rich, with two β‐
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sheets. Hepcidin exhibits both antimicrobial activity and iron‐regulatory activity
(Ganz 2006).
More recently, additional categories have been informally added to include newly
discovered proteins and proteins with previously defined functions to which
antimicrobial activity has been newly ascribed. One group is the aromatic dipeptides,
which comprise low molecular weight compounds isolated from dipteran larvae (e.g. N‐
β‐alanyl‐5‐S‐glutathionyl‐3,4‐dihydroxyphenylalanine and p‐hydroxycinnamaldehyde)
(Vizioli et al. 2002).
Mechanism of Action of Antimicrobial Peptides
Most antimicrobials are cationic peptides, whose positive charge provides some
selectivity towards negatively charged microbial cell outer membranes and
cytoplasmic membranes. This specificity allows for differentiation between the
microbial cells and host cells, and reduces cytotoxicity to host cells because their cell
membrane invariably contains a higher percentage of cholesterol than bacterial cells
(Diamond et al. 2009). The precise mechanism of action of antimicrobial peptides has
been well studied, but still not completely understood. Their cationic charge leads to a
high degree of potency in their antimicrobial activities. This is because of the presence
of multiple lysine and arginine residues, a large portion of hydrophobic residues (50%
or higher) and amphipathicity (Zasloff 1987; Hill et al. 1991; Park et al. 2000). Methods
such as fluorescent dye release in model membrane systems (Ladokhin et al. 1997),
ion channel formation (Christensen et al. 1988) and measurement of secondary
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structure (Wu et al. 1995; Bechinger et al. 2004; Lee et al. 2004) have helped to discern
several proposed mechanisms of activity.
It is generally accepted that antimicrobial peptide‐mediated killing of microbes occurs
through membrane permeation, but not exclusively. For example, non‐membrane
disruptive methods have also been observed (Diamond et al. 2009). The ability to kill
bacteria via pore formation requires three key steps: binding to the bacterial
membrane, aggregation within the membrane, and formation of channels. The
channel formation leads to cell death via leakage of internal cell contents. In order to
carry out this process, an antimicrobial peptide (often referred to as AMP) must cross
the negatively charged outer membrane of gram‐negative bacteria which contains
lipopolysaccharides (LPS), or the outer wall of gram‐positive bacteria, which contains
acid polysaccharides (Hancock et al. 1997; Palffy et al. 2009). The three most
established pore forming models are the barrel‐stave pore, the thoroidal pore, and the
carpet model (Lehrer et al. 1989; Hancock 1997; Oren et al. 1998; Palffy et al. 2009). In
the barrel‐stave pore model, AMP binds to the negatively charged membrane to form
dimers or multimers. Multimers of AMP cross the cell membrane so that the
hydrophobic region is facing the lipid bilayer, and the hydrophilic region is facing the
lumen of the pore. The assembled peptides form barrel‐like channels resembling
staves (Ben‐Efraim et al. 1997). The thoroidal pore model shares a common
mechanism with the barrel‐stave pore model. However, in this model, the AMP forms
a monolayer by connecting the outer and inner lipid layers in the pore (Lehrer 1989;
Hancock 1997; Oren et al. 1998; Palffy et al. 2009). The carpet model has peptides
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covering the outer surface of the membrane, thus the peptides act as detergents,
disrupting the membrane bilayer after reaching a threshold concentration. The pores
are formed from micelle‐like units (Oren et al. 1998; Palffy et al. 2009).
Additional models have been suggested that are specific to one or other AMP. This
includes molecular electroporation, where some peptides are able to create
electrostatic potentials across the bilayer sufficient for pore generation (Chan et al.
2006; Palffy et al. 2009). Other methods involve peptides binding to the endotoxin
moieties of bacterial LPS (such as defensins and cathelicidins) (Bals 2000; Palffy et al.
2009). Some AMPs inhibit DNA synthesis, protein synthesis, or both (Gennaro et al.
2002; Boman 2003). Histatin targets the mitochondria of fungal pathogens (Tsai et al.
1998).
Histones historically have been associated with DNA stabilization, playing a crucial
role in the packaging of DNA, thereby ensuring efficient replication and segregation of
the chromosomes. Histone gene transcription is coordinated with the cell cycle and
regulated by cyclins and D‐type cyclins, CDKs (Ewen 2000). They are divided into two
functional types: 1) core histones, which are comprised of histones H2A, H2B, H3 and
H4, and together form an octameric complex (about 146 basepairs of DNA) to create
the nucleosome; and 2) linker histones, H1, which seal loops of DNA that enter and
leave nucleosomes and condense these structures into compact, higher order fibers.
The structure of core histones does not differ much among species. The H1 histones,
however, are the largest and most heterogeneous family of histones and much more
varied (Smith 1991; Hiemstra et al. 1993). These proteins show structural variations
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not only among but also within species (Kawasaki et al. 2008). These variations can be
explained by any number of post‐translational modifications such as acetylation,
methylation, poly‐(ADP ribosyl)ation, ubiquination, sumoylation and perhaps even
phosphorylation (Parseghian et al. 2006).
Despite being historically associated with DNA packaging, histones are not
confined to the nucleus. It has been found that after biosynthesis in the cytosol by
free ribosomes, a limited amount of histone is accumulated. These are imported to
the nucleus via karyopherins (also known as importins), while the excess
(unacetylated) histones accumulate in the cytoplasm, especially in rapidly regenerating
or transcriptionally active cells (Zlatanova et al. 1990; Watson et al. 1995; Chang et al.
1997; Augusto LA 2003). Secretion of cytoplasmic histone extracellularly has been
observed (Watabe et al. 1996; Brix et al. 1998; Augusto LA 2003), and extracellular
histones are released from apoptotic cells (Schwartz et al. 1993). Histones may also be
found on the cell surface, as evidenced by binding of sulfated polysaccharide D2S to
the surface of T‐cells. Using ligand‐studies and immunoblotting techniques, histone H2
was found to be the ligand on the surface of the T‐cell (Watson et al. 1995).
Consequently, histones are quite ubiquitous, having been shown to be present in the
cell nucleus, cytosol, cell membrane, and extracellular environment (Parseghian et al.
2006).
There are several possible explanations as to why histones, usually associated with
DNA stabilization, have shown antimicrobial activity. It has been suggested that a
structural motif of histone, which strongly binds to DNA, may be used as an
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antimicrobial peptide to bind to the cell membrane of invading microorganisms (Park
et al. 1996). Studies (Frank et al. 1990; Lehrer et al. 1992) have shown that one main
biological action of antimicrobial peptides such as defensins and bactenecins involve
lipid and membrane binding. Since a single biologically active compound can have
more than one kind of macromolecule‐binding activities, it can be hypothesized that
the isolated peptides adopted the histone‐like structure to bind strongly to lipids of
cell membranes, which is necessary for antimicrobial activity (Frank et al. 1990; Lehrer
et al. 1992; Park et al. 1996).
Other studies have revealed yet another function of histones. Researchers have
observed that histones have a remarkably high affinity for LPS. In lung epithelial cell
lines they found that the most efficient LPS binding proteins were two histones, H2A.1
and H4. However, to be effective, the entire 3D structure of the histone is required to
be intact (Augusto et al, 2003). It has also been reported that the major LPS‐binding
protein in the brain is an isoform of histone H1, predominantly located at the neuronal
cell surface (Bolton et al. 1997).
Histones as Novel Antimicrobial Peptides
In leukocytes, antimicrobial peptides are sequestered in granules. In response to
an infection, the leukocyte is activated and, following phagocytosis of microorganisms,
its cell content degranulates releasing hydrolyzing enzymes, antimicrobial peptides
and other effector molecules to the infection site. As these granules contain acid
soluble enzymes such as lysozyme, ribonucleases and deoxyribonucleases; the nature
of antimicrobial substances was difficult to distinguish from the histones and
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protamines found in the nuclei (Zeya et al. 1966; Isenberg 1979). Investigators have
since been able to attribute antimicrobial activity specifically to histones and their
related fragments, working independently or synergistically with each other and other
peptides (Rose et al. 1998; Agerberth et al. 2000; Kim et al. 2000; Patrzykat et al. 2001;
Kawasaki et al. 2008). Histones that possess such broad spectrum antimicrobial
activity have been found in shrimp (Patat et al. 2004), teleost fish (Robinette et al.
1998; Noga et al. 2001; Richards et al. 2001; Fernandes et al. 2002; Bergsson et al.
2005), frog (Kawasaki et al. 2003), chicken (Silphaduang et al. 2006; Li et al. 2007) and
mammals (Hiemstra et al. 1993; Rose et al. 1998; Kim et al. 2002; Howell et al. 2003;
Jacobsen et al. 2005) (reviewed in Kawasaki and Iwamuro 2008).
Purified histone H1 was found to be expressed in the cytoplasm of intestinal villus
epithelial cells, and upon detachment of the epithelial cell, was released as the cell
underwent programmed cell death (i.e., apoptosis) (Rose et al. 1998). It was
suggested that H1 may protect villus epithelial cells against penetration by
microorganisms (Rose et al. 1998). Immunohistochemistry studies show that H1 is
found in the nucleus, affording the cell continued protection even after the
microorganism had penetrated through the cell membrane (Rose et al. 1998). In
flounder, there is additional evidence that synthesized histone H1 may work
synergistically with flounder pleurocidin to potentiate and enhance its antibiotic
effects against fish pathogens (Patrzykat et al. 2001). In the chicken, full length histone
H1, as well as H2B, were purified from extracts of the ovary and oviduct, and were
active against both gram negative and gram positive bacteria, but a high salt
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concentration was required for histone H1 to express the activity against the gram
negative bacteria (Silphaduang et al. 2006). A histone H1 fragment has been isolated
from skin secretions of rainbow trout, termed oncorhyncin II, with broad spectrum
antimicrobial activity against not only bacteria, but also fungi (Fernandes et al. 2004).
Histone H2A is the best studied member of this family of proteins, and the full
length protein has been isolated from human placenta (Kim et al. 2002), chicken liver
(Li et al. 2007), and rainbow trout (Fernandes et al. 2002). Histone H2A fragment was
isolated from gastric tissue of the Asian toad and results of the study provided further
evidence of the association of histones with cells undergoing apoptosis (Park et al.
1996). The toad histone H2A fragment was found to be a precursor of Buforin I, a
potent 39 amino acid antimicrobial peptide. These instances provided further
evidence that histones play a major role in host defense (Park et al. 1996, 2000). By
substituting an amino acid on Buforin I, a H2A‐derived antimicrobial peptide was
generated that showed a broad‐spectrum of activity against several microorganisms,
but did not kill microbes by cell lysis. This modified antimicrobial agent had a strong
affinity for DNA and RNA, suggesting that it targeted intracellular substances like
nucleic acids (Park et al. 2000). This observation indicates an enormous potential for
the production of a new class of antibiotics (Barra et al. 1998; Boman 1998). Two other
forms of histone H2A‐related peptides (fragments) have been found in the skin mucus
of fish, Parasin I, from the skin mucus of a wounded catfish (Park et al. 1998) and
hipposin, from the Atlantic halibut (Birkemo et al. 2003).
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Histone H2B was first isolated from the cytoplasm of mouse (murine) macrophage
cell lines, RAW264.7 and J774A.1 (Hiemstra et al. 1993). It has also been isolated from
colonic epithelial cells in tandem with H1 (Howell et al. 2003). Calf intestinal H2B was
found to have anti‐parasitic activity, similar to the histone H1‐like protein isolated
from the skin, gill, and spleen extracts of rainbow trout and sunshine bass (Noga et al.
2001). Histone H2B fragments have been isolated from extracts of human blister
wound fluid, which displayed very high activity against gram positive bacteria (Frohm
et al. 1996).
There are few reports of the antimicrobial activity of histones H3 and H4, not
because they are less studied, but because of their pattern of co‐purifiying with other
histones like histone H2B (Kawasaki et al. 2008). Recently, however, investigators have
reported on the antimicrobial activity of histone H4 (Lee et al. 2009). A novel histone
antimicrobial peptide, synthesized from buforin II, shows homology to histone H3 with
broad spectrum antimicrobial activity (Tsao et al. 2009).
Augusto et al. (2003) observed that the affinity of histones for bacterial
lipopolysaccharides (LPS) is higher than that of polymyxin B, an antibiotic known to
block several biological activities of LPS. This affinity indicates that the therapeutic
potential of histone analogues may (as with other LPS‐binding molecules) reduce
bacterial growth, facilitate bacterial opsonization, or directly block the interaction of LPS
with host pro‐inflammatory pathways.
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Immunomodulatory Effects of Antimicrobial Peptides
The synthesis of enteric defensins in human fetal tissue starts 13.5‐17 weeks after
gestation, and it has been shown that LL37 and members of the defensin family are
present in amniotic fluid (Mallow et al. 1996; Yoshio et al. 2004). It was once the
prevailing thought that an antimicrobial peptide’s only function was as a microbicidal
agent. It has since come to light that this is only one aspect of these astonishing
molecules. Antimicrobial peptides (AMPs) have the capacity to regulate epithelial cell
proliferation, enhance wound healing (Frohm et al. 1996), inhibit or induce pro‐
inflammatory cytokines (Nagaoka et al. 2001), take part in angiogenic and anti‐
angiogenic processes (Li et al. 2000), stimulate chemokine production (Bowdish et al.
2005), facilitate chemotaxis of various leukocytes (Huang et al. 1997), influence mast
cell degranulation (Befus et al. 1999) and modulate host cell gene expression (Kelly et al.
2006). To the surprise of mainstream immunologists, these relatively obscure peptides
have been implicated in helping to modulate adaptive immune function. A number of
studies have reported that co‐administering antimicrobial peptides with relatively
benign antigens results in the enhancement of the host’s cell mediated and humoral
immune responses to these antigens (Lillard et al. 1999; Tani et al. 2000; Brogden et al.
2003). These findings strongly implicate α‐defensins as immune adjuvants that promote
T cell‐dependent cellular immunity as well as antigen‐specific immunoglobulin
production (Lillard et al. 1999). Furthermore, it has been postulated that antimicrobial
peptides may be modulating lymphocyte responses, modifying cytokine expression
during antigen presentation and possibly causing maturation of immature dendritic cells
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by inducing co‐stimulatory molecules, resulting in more effective antigen presentation
and subsequent robust T cell activation (Funderburg et al. 2007; Diamond et al. 2009).
Peptides have also been shown to act as cofactors to lower lethality of a
hyperinflammatory response (Steinstraesser et al. 2009). Endotoxin, found on the
outer layer of gram‐negative bacteria, is recognized as harmful and activates the
innate immune system. In some cases, antibiotics can cause endotoxin release which
can be neutralized by the antimicrobial peptide LL‐37, thus inhibiting the production of
pro‐inflammatory cytokines such as tumor necrosis factor‐α and IL‐6 (Zanetti et al.
1995; Scott et al. 2002).
Significance of Antimicrobial Peptides
The number of known antimicrobial peptides is rapidly increasing. So far over
1,220 peptides have been characterized, including over 940 peptides from eukaryotic
organisms (Steinstraesser et al. 2009). There are three databases that list
antimicrobial peptides. These are the ANTIMIC, AMPer and APD2 (Brahmachary et al.
2004; Fjell et al. 2007; Wang et al. 2009) databases. AMPs differ in their structure,
physicochemical characteristics and biological function. They also differ in their
mechanisms of action, as well as their antimicrobial activities (non‐cationic peptides
tend to have weaker bactericidal activity than do cationic peptides) (Vizioli et al. 2002).
It has been shown that antimicrobial peptides can kill susceptible bacteria in vitro at
concentrations up to 4 g/ml (Hancock et al. 1998); beyond that concentration there is
the risk of host cell toxicity. Antimicrobial peptides have been shown to play a
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significant role in the prevention of disease (Hancock et al. 1998; Rivas‐Santiago et al.
2009). There are scores of studies on the susceptibility to infectious disease on the
basis of the level of antimicrobial peptide production by the host. During primary
infection, the level of inflammation is directly related to the immune response
mounted by the host. Recruitment of inflammatory cells by chemokines and
production of pro‐inflammatory cytokines and release of antimicrobial peptides will
determine the outcome of infection (Rivas‐Santiago et al. 2009). Antimicrobial
peptides play key roles in infectious diseases of the skin. In atopic dermatitis, viral and
bacterial infections complicate successful therapy as they can lead to cutaneous
inflammation. It has been shown that these patients have a significantly lower
production of dermcidin 1 than do healthy subjects (Schittek et al. 2001; Rivas‐
Santiago et al. 2009). Another skin condition, atopic eczema, is associated with
decreased expression of human β‐defensin‐2 (HBD‐2), HBD‐3 and LL‐37, which can
lead to skin infections with Staphylococcus aureus (Ong et al. 2002; Nomura et al.
2003; Rivas‐Santiago et al. 2009). Psoriasis is another example of human inflammatory
skin disease associated with abnormal antimicrobial peptide expression. Cathelicidin is
increased in lesional skin in these patients (Ong et al. 2002; Rivas‐Santiago et al. 2009).
These studies have important implications on the use of cathelicidins and others in
skin infection control. Clinical applications of antimicrobial peptides in treating burn
wounds have also been examined. In one study, transient cutaneous adenoviral
delivery of LL‐37 resulted in significant bacterial inhibition that might be a potential
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adjunct for wound treatment in the near future (Jacobsen et al. 2005; Rivas‐Santiago
et al. 2009).
Antimicrobial peptides have also been studied in gastrointestinal infections as the
healthy intestinal tract is characterized by a sensitive balance of host antimicrobial
peptides and intestinal microbes. For example in some African adults, low α‐defensin
expression appears to be associated with a higher risk of infectious diarrhea (Kelly et
al. 2006; Rivas‐Santiago et al. 2009).
Members of the three main peptide families are found in the oral cavity: LL‐37, α‐
and β‐defensins and peptides with an unusually high proportion of specific amino
acids, such as histatins (Dale et al. 2006; Rivas‐Santiago et al. 2009). In Morbus
Kostmann, a genetic disorder, patients experience frequent oral bacterial infections
and severe periodontal disease, which correlate with a deficiency in the production of
cathelicidin peptide LL‐37 and α‐and β‐defensins (Dale et al. 2006; Rivas‐Santiago et al.
2009).
Systemic infectious diseases that are caused by viruses such as the HIV virus have
been shown to be vulnerable to β‐defensins as they seem to compete for the same
chemokine receptor, so the virus is unable to enter the cell. The β‐defensin then
seems to confer a protective response to the host (Garzino‐Demo 2007; Rivas‐Santiago
et al. 2009).
Lung infections caused by infiltration and growth of Mycobacterium tuberculosis
have been shown to be marginally controlled by the presence of high levels of
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cathelicidin, LL‐37, in epithelial cells, neutrophils, and alveolar macrophages (Rivas‐
Santiago et al. 2006).
The studies mentioned above all suggest there is efficacy in the possible use of
certain antimicrobial peptides in therapy as an alternative treatment option in the
management of infectious diseases (Rivas‐Santiago et al. 2009).
Significance of Elasmobranchi as a Model System
In the rapidly evolving area of inquiry into the nature of antimicrobial peptides,
there are many questions that still exist. These include:


How ubiquitous are these proteins and peptides in nature?



What other animals express these proteins and peptides?



What are their mechanisms of action?



How have these proteins and peptides evolved in the development of
vertebrate and invertebrate immunity?

There is a need for more study in this area, using varied animal systems. The nurse
shark, Ginglymostoma cirratum, which belongs to the class Elasmobranchi, is a basal
vertebrate with a fully developed innate and adaptive immune system. This basal
animal is strategically placed in the phylogenetic lineage and is a good model to study
unresolved questions regarding antimicrobial peptides in primitive vertebrates. The
nurse shark’s natural antibodies, spontaneous cytotoxicity, and complement have
been studied, and are believed to work in concert to form an immunosurveillance
system seeking out new antigens (Rudikoff et al. 1970; Clem et al. 1982; Pettey et al.
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1983; Smith et al. 1986; Flajnik 1994; Parham 1995). In addition, innate system
components such as antibacterial proteins/peptides and other antimicrobial
substances may form the basis of innate immunity necessary to maintain a healthy
animal, particularly during times of stress. Nurse sharks inhabit tropical and
subtropical waters on the continental shelf, and can be found along the Western and
Eastern Atlantic coasts; along the islands of the Caribbean; as well as the Eastern
Pacific coast. Nurse sharks have been known to inhabit polluted waters, as they are
bottom dwellers of shallow warm waters (Fange et al. 1981). In this environment the
nurse shark is at a greater risk to infectious agents than animals that inhabit deeper
and more open waters (which are less likely to be polluted), and runs a greater risk of
physical trauma as a result of man’s intrusion into its habitat (Reif 1978). For these
reasons, an efficient immune system with innate and adaptive immune mechanisms is
essential for its survival. Because of the critical role of innate immunity in the
development and survival of this species, Ginglymostoma cirratum makes a good
animal model to study, aided by the fact that it is one of a few shark species that can
be successfully maintained in captivity for long periods (Clark 1963). The nurse shark
has a less well developed adaptive immune system compared to mammals, therefore
it would be expected that a non‐specific antibacterial response to pathogens would
play a more significant role when mounting an immediate immune response.
Goals and Hypothesis
This study was undertaken to test the hypothesis that in addition to lysozyme, nurse
shark peripheral blood leukocytes possess antibacterial factors that include histone
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fragments. The specific goal was to demonstrate antibacterial activity in crude
leukocyte lysates, against a target bacterium, Planococcus citreus, and to determine its
mode of action.
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III. MATERIALS AND METHODS

A. MATERIALS
Details of the buffers, reagents, solutions, culture media preparation, protocols for the
preparation of acrylamide gels, western blot buffers and antisera preparation and
concentration can be found in Appendix I.

B. METHODS
Blood Collection
Initially several (8‐10) nurse sharks (Ginglymostoma cirratum), males and females,
ranging in size from 1.5 ‐2 meters (5‐7 feet) were maintained in a seawater channel at
the Keys Marine Laboratory, Long Key, Florida Keys. Following the loss of all animals in
a hurricane, a newly acquired, single female animal, about 1.2 meters (4 ½ feet), was
maintained and bled at 6‐8 week intervals to obtain 60 ml of blood. The shark was
anesthetized in a rectangular tank of seawater containing 1 ppm 3‐aminobenzoic acid
ethyl ester (methanesulfonate salt). The anesthetized shark was bled by placing it in a
horizontal position on its back, on a clean surface, and withdrawing blood with a 20
gauge, 1½ inch needle from the caudal vein using a 60 ml syringe. The animal was then
returned to the channel and manually moved back and forth through the water until
normal gill respiration returned before release. This work was conducted with
institutional IACUC approval.
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Preparation of Cytospins
Blood smears were prepared from a nurse shark leukocyte‐enriched suspension to
evaluate cell morphology and to acquire differential counts. Nurse shark heparinized
whole blood (1000 units/ml) was left to settle for 2 hours. The buffy coat was removed
(with a thin layer of erythrocytes attached) and spun at 435 x/g (1240 rpm) for 10
minutes (min) at 15°C. The leukocyte enriched pellet was resuspended and washed
with sRPMI at 435 x/g (1240 rpm) for 10 min at 15°C. The wash was decanted and the
pellet was resuspended to 1 x 105 cells/ml. 250 l of the cell suspension was loaded
onto a cytospin chamber loaded with a poly‐L‐Lysine coated microscope slide and
centrifuged in a cytocentrifuge (Cytopro, Wescor), at 250 x/g (1200 rpm) for 3 min at
room temperature. The leukocyte enriched monolayer was air‐dried and stained with
leukostat stain for morphological identification of nurse shark peripheral blood cell
populations.

Isolation of Peripheral Blood Leukocytes
Freshly collected nurse shark blood was aliquoted in 15 ml polypropylene, screw
cap tubes containing anticoagulant. Blood (9 ml) was added to 1 ml of 3.8% trisodium
citrate in shark RPMI media (0.35M urea, 0.2 M NaCl, pH 7.4), to give a final
concentration of 0.38% anticoagulant. The tube was inverted gently several times
until complete mixing was achieved, and blood samples were transported on ice to the
lab for processing.
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Anticoagulated blood was diluted with an equal volume of shark RPMI. Using a
long pasteur pipette, 24 ml of the diluted blood sample was withdrawn and layered
carefully onto the surface of 18 ml of a gradient mixture consisting of two parts
Lymphocyte Separation Media, LSM (Sigma, MO), and one part physiological saline
(0.15 M NaCl) in a 50 ml centrifuge tube. The sample was centrifuged at 435 x/g (1240
rpm) for 30 min at 15C in a Beckman GPR centrifuge (brake off). A small volume of
whole blood was retained to determine the total white cell count and differential
counts. Following centrifugation, the cloudy interface layer along with the thin buffy
coat layer present on the surface of sedimented erythrocytes was removed and
transferred to a sterile 15 ml tube. The harvested leukocytes were separated by
centrifugation at 435 x/g (1240 rpm) for 20 min at 15°C. Any remaining contaminating
erythrocytes in the pellet were lysed by hypotonic lysis; the pellet was resuspended in
approximately 5 times its volume in 0.2% NaCl by inverting several times to resuspend
cells completely (this permitted all cells to be lysed by the hypotonic lysing solution).
Then an equal volume of 2.5% NaCl was added to the solution of 0.2% NaCl solution to
neutralize the effect of the lysing solution. The suspension was centrifuged at 435 x/g
(1240 rpm) for 15 min at 10°C and the supernatant discarded. The pellet of isolated
leukocytes was resuspended in 1‐2 ml of 0.25 M NaCl, isotonic for shark leukocytes.
Using a small aliquot of the leukocyte suspension, a total cell count was determined
manually using a haemocytometer and used to calculate the leukocyte yield. A
viability test was also performed (employing the trypan blue exclusion test) to confirm
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that cells were viable and intact and not ‘leaking’ intracellular contents. The cell
suspension was stored at ‐20C until ready to use.

Trypan Blue Exclusion Test
The trypan blue exclusion test was used to determine the viability of shark cells
because live, viable cells with intact cell membranes, exclude certain dyes, such as
trypan blue. For experimental purposes a cell viability of 95% or higher was deemed
optimal for biological assays. A 10 µl aliquot of cell suspension was diluted in 1 ml
0.25M NaCl and 10 µl removed and mixed 1:2 with cell viability reagent. After 3 min
incubation at room temperature (RT), a drop of suspension was applied to a
haemocytometer and viewed under the 40x objective lens. The stained (nonviable)
and unstained (viable) cells were counted separately up to a total of 200 cells. The
percent viability was calculated as follows:
Percent viable cells = # viable cells per 200 cells
200 cells

x 100

Preparation of Leukocyte Lysates
Cell lysates were prepared from the frozen suspended pellets (isolated using LSM)
by first freezing and thawing to facilitate lysis. The cell pellets were thawed at room
temperature, refrozen at ‐80°C, and then thawed again. Once thawed, the cell
suspension was held on ice. The repeated freeze‐thaw treatment facilitated
subsequent disruption of cells by mechanical shearing using a glass homogenizer
and/or ultrasonic disruption in a sonicator (Sonicator 3000, Misonix). For sonication of
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cell pellet, 0.25M NaCl was added to the cell suspension. A 2 ml cell suspension was
placed in a 15 ml screw cap tube, and immersed in a beaker filled with ice and
sonicated at 18‐27 watts for 10 min with 1 min pulses and 2 min rest periods in
between pulses. Efficiency of disruption was confirmed by microscopic examination of
the sonicated suspension for complete disruption of cells with intracellular contents
expelled. The resulting cell lysate was collected by centrifuged for 90 min at 21,000 xg
at 7°C (Micromaxx FF, IEC) to pellet the debris. The cell lysate supernatant (CLS) was
removed and stored at ‐20C as small aliquots of 2 ml in eppendorf tubes. Protein
concentration of each leukocyte lysate preparation was determined using the BCA
colorimetric protein assay protocol (Pierce, IL).

Concentration and Dialysis of Lysates
Each cell lysate supernatant was thawed and clarified by centrifugation for 5 min at
1000 xg (Micromaxx FF, IEC) to sediment any precipitated material which may have
formed as a result of freezing. Lyophilization was used to concentrate samples.
Dialysis: For chromatography, lysate samples were dialyzed against the column
equilibration buffer using Spectra Por Dialysis Tubing with a 3000‐D cutoff. Dialysis
was carried out for up to 8 hours at 4°C with buffer changes every 2 hours (h).
Lyophilization: Before being subjected to lyophilization, high salt samples (e.g.,
column fractions eluted at high salt) were first dialyzed (as per above). The thawed
samples were placed in 50 ml polypropylene tubes and freeze‐dried (Freezedryer,
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Labconco) for 12‐18 hours. The lyophilized samples were reconstituted in a small
volume of ddH2O to obtain a 4‐10 fold concentration of the sample.

Detection and Quantitation of Antibacterial Activity
Screening methods
(1) Lysoplate assay
The lysoplate assay was used as a screening method to assay for lysozyme
(muramidase) activity. The lysoplate method was originally developed by
Osserman and Lawlor (1966) and later modified by Manchenko (1994). A 0.12%
(1.2 mg/ml) stock suspension of lyophilized Micrococcus lysodeikticus cell walls in
0.06M phosphate buffer, pH 6.2 was prepared and stored as 50 ml aliquots at 4C.
Lysoplates were set up by preparing an agarose lawn in 0.06M PB, pH 6.2,
containing a suspension of Micrococcus lysodeikticus cell walls (0.06% final
concentration). To prepare a lysoplate, the Micrococcus lysodeikticus cell wall
suspension was removed from the cold and equilibrated to 55°C before being
added to the agar medium.
To prepare the plates equal volumes (5 ml each) of 2% agarose and 0.12%
bacterial cell wall suspension, equilibrated to 55°C for one hour in a water bath,
were gently mixed together to a final concentration of 1% agarose and 0.06% cell
wall suspension, and poured into a square petri dish marked with a grid (Fisher
Scientific, GA). Wells (3 mm diameter) were punched into the solidified agar at the

37

center of each grid square using the sterile tip of a 3mm diameter template cutter
(ICN, OH). The cell lysate samples were thawed and kept on ice prior to the assay.
Each well was filled with 5 l of test sample. Negative controls consisted of
distilled water, buffer or salt solutions, while chicken egg white lysozyme (final
concentration 0.01 mg/ml) was used as a positive control. Assays were set up in
duplicate. Once sample material diffused from the well into the agar, the plates
were inverted and incubated at 37C for 24 hours. Plates were examined for zones
of clearing (indicative of cell wall lysis) around the wells and the diameter of the
zones (measured as an average size of duplicate tests) recorded. Lysozyme activity
was calculated in arbitrary units, as follows. The diameter of the well (3 mm) was
subtracted from the diameter of the zone of clearing, and using the relationship of
0.1 mm diameter size equal to 1 unit (U) of enzyme activity (Lehrer et al. 1991) the
enzymatic activity was estimated.
(2) Agar Diffusion assay
The agar diffusion assay was used as an initial screening method to detect
antibacterial activity. The original protocol developed by Lehrer (1991) was
modified. In place of marine broth an artificial seawater medium, enriched with
peptone and yeast extract (Makemson et al. 1998) was used, which provided a
clearer agar medium (minimal precipitation) and permitted sharper visualization of
antibacterial activity. The supplemented sea water medium supported good
growth of Planococcus citreus, used as the target bacterium in experiments.
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Planococcus citreus, a salt tolerant Gram positive coccus, was used as the
target organism in the antibacterial assay to detect antibacterial activity of shark
cell lysates. Stock cultures of P. citreus were maintained at 30C on agar plates
and slants of artificial sea water complete agar (SCA) and subcultured every other
day. Stock cultures were stored at 4C. From a 48h SCA plate culture, P. citreus
was inoculated into 50 ml artificial sea water complete broth (SCM) in a 125 ml
conical flask and grown to log phase for 6‐8 hours at 30C in an incubator. A 5 ml
aliquot of broth culture was then removed and added to fresh medium (50 ml) and
incubated further for 8 hours at 30C. The broth culture was centrifuged (1085 x g
for 5‐7 m) and the sedimented bacterial pellet was resuspended in SCM. For the
radial diffusion assay, the resuspended bacterial pellet was washed twice with
3.2% NaCl solution. The bacterial suspension was standardized to an OD 580 nm of
0.5 which corresponded to a bacterial count of approximately 106 CFU/ml. Before
use in the agar diffusion assay, the agar stored in screw cap tubes was melted in a
boiling waterbath (Tek‐Bath, Tek‐Pro), then cooled to 44C in a water bath before
addition of 100l of the target organism P. citreus, (106 cells/ml), to the molten
agar. The mixture was stirred carefully to evenly suspend the bacteria, poured into
10 cm sterile petri dishes, and allowed to solidify at room temperature. The assay
plates were stored at room temperature and used within the hour to set up the
acid‐urea overlay assays.
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The P. citreus inoculum for microdilution growth assays was prepared as
described above for the agar diffusion assays, however, the sedimented bacterial
pellet was resuspended in SCM, and standardized to an OD 580 nm of 0.15 which
corresponded to a bacterial concentration of approximately 2.5 x 104 CFU/ml
(determined as above).
Microdilution growth assay
The agar diffusion assay was limited in sensitivity and only provided a rough
estimate of the level of antibacterial activity. It was necessary to design an assay with
increased sensitivity to detect antibacterial activity and which could be used to
measure the level of activity. Since no such assay had been described for shark
antibacterial proteins/peptides, an essential part of this study was to develop a
microdilution growth assay. Initially the assay was developed using sea water
complete broth (SCM) medium and Planococcus citreus as the target organism. The
reaction mix for the assay consisted of 50 µl of test sample (cell lysate supernatant),
75µl of 2x SCM and 100 µl of log phase P. citreus standardized to 2.5 x 104 CFU/ml. The
assay was set up in a polypropylene microwell plate (VWR, PA) and each sample was
set up in triplicate. The plates were mixed on a microplate shaker for 5 min, and
absorbance read at OD570nm, which served as a 0 h reading (t=0). The plate was further
incubated at 30°C for 12 hours and absorbance read again every two hours at OD570nm.
Extrapolating from the growth curve of P. citreus the end point of the assay was
established at 12 h when maximum growth is obtained. Assays were set up in
triplicate as follows, with each triplicate consisting of a medium control (225 µl of 2x
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SCM), culture control (50 µl of 1x SCM as diluent, 75µl of 2x SCM and 100µl of log
phase P. citreus), lysate control (50 µl of cell lysate supernatant and 175µl of 2x SCM),
and defensin control (50 µl α‐defensin, HNP1 (25 µg/ml), 75µl of 2x SCM and 100µl of
log phase P. citreus).
To determine optimal assay conditions for maximal sensitivity for detecting
antibacterial activity, the assay was set up at varying incubation temperatures, pH, and
salinity, and using different cell densities of the P. citreus culture. Once conditions
were optimized, the standard assay was routinely used to detect antibacterial activity
in samples.
Optimal pH for detecting antibacterial activity was determined by setting up
standard assays using assay medium adjusted to pH values of 4.0, 5.5, 6.5, 7.5 and 8.5.
One volume of the sample was mixed with two volumes of the pH adjusted medium
and 50 µl was used to set up the standard assay using pH‐adjusted medium
corresponding to that of the treated sample. A similar protocol was followed to
determine optimal ionicity using media adjusted to NaCl concentrations ranging from
0.3 M to 0.6 M. Controls as described above for the standard assay were included. For
all experimental assays, the normal growth of P. citreus and the antibacterial effect on
the growth of P. citreus was monitored by measuring OD at specific time intervals up
to 12 hours. Optimal incubation temperature was determined by performing the assay
at 30°C and RT (~25°C).
To determine the optimal concentration of P. citreus to develop a highly sensitive
assay capable of detecting relatively low levels of antibacterial activity, assays were
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designed using three different concentrations of target organism. A bacterial
suspension, standardized to 0.5 at OD 580 nm, which corresponded to a bacterial count
of approximately 106 CFU/ml, was diluted 1:10 (1x105 CFU/ml), 1:20 (5x104 CFU/ml)
and 1:40 (2.5x104 CFU/ml) with 1x SCM. Five hundred l of each concentration of
bacterial suspension was plated onto SWA plates and incubated for 18 hours at 30°C.
The colony forming units were calculated from these plates to confirm each bacterial
suspension concentration.
The microdilution growth assay was also used as a quantitative assay to measure
the level of antibacterial activity in samples. Quantitative assays were set up by adding
50 µl of the test sample to 50 µl of diluent (1x SCM) in the second well and continuing
to serially dilute the sample up to 1:32 dilution using 2‐fold serial dilution in SCM. The
first well contained 50 µl of undiluted sample. Each assay was set up in triplicate. The
microtiter plates were mixed on a microplate shaker for 5 min, and absorbance read at
OD570nm. The plate was further incubated at 30°C for 12 hours and absorbance read
again at OD570nm. The level of activity was calculated from OD reading and expressed as
a titer and measured as percent inhibition using the formula:
Percent Inhibition = OD570nm of P. citreus control‐ OD570nm of sample X 100
OD570nm of Planococcus citreus control
Antibacterial titer was defined as the inverse of the highest dilution of the test
sample that showed inhibition (>5%) of growth of the target organism (Herbert et al.
1977).
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Fractionation of Cell Lysates
Screening of cell lysate supernatant showed two distinctly different activities, a
lysozyme‐like activity and non‐lysozyme‐like antibacterial activity. In order to separate
the molecules responsible for these two activities, ion exchange and affinity
chromatography were undertaken. Earlier studies showed that recovery of
antibacterial activity from cation exchange chromatography was not optimal (low
recovery of activity). Therefore, initial fractionation of cell lysates was accomplished
by anion exchange chromatography employing a weak (DE‐52 cellulose, Whatman), a
medium strength (DE Sepharose, Pharmacia), and a strong (Q‐sepharose, Pharmacia)
ion exchanger. The use of different ion exchangers was carried out to determine
which protocol would achieve optimal separation and yield significant recovery of
antibacterial activity. Following chromatographic separation active fractions were
pooled and further fractionated by affinity chromatography on a heparin affinity
column. All chromatography was carried out at room temperature (25°C) and columns
were run using a peristaltic pump at a constant flow rate. Fractions were collected
and OD 280/260 nm read manually on a spectrophotometer (Ultraspec 3000, Pharmacia).
Fractions were assayed for antibacterial activity using the standard microdilution
growth assay while lysozyme activity was screened using the lysoplate assay. Active
fractions were pooled, concentrated by freeze‐drying, and reconstituted in smaller
volumes of ddH2O. The concentrated pools were stored at ‐20C until needed for
further processing.
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Anion exchange chromatography using DE 52 Cellulose
Preswollen diethyl aminoethyl cellulose (DE 52, Whatman), a microgranular
cellulose matrix, was rehydrated in 0.02 M Tris‐HCl, 0.05 M NaCl, pH 7.5. The pH of the
suspension was adjusted to 7.5 with 10 N NaOH. The buffer was decanted and
discarded, and the gel washed several times with equilibration buffer (0.02 M Tris‐HCl,
0.05 M NaCl, pH 7.5) until the pH and ionicity of the gel mix was the same as the
equilibration buffer. A column measuring 1.0 cm diameter x 4.5 cm in length was
poured (bed volume of 3.6 ml), and equilibrated with 20 ml equilibration buffer. The
flow rate was adjusted to 0.5 ml/min and 0.75 ml fractions were collected. Sample
material was mixed with equilibration buffer in a ratio of 3:1, before being applied to
the column. The column was washed until all unbound protein had been collected and
the OD280nm of the eluant was the same as the equilibration buffer. Proteins bound to
the column were eluted with a linear NaCl gradient formed in a gradient mixer (Hoefer
SG‐100, Pharmacia) using an equal volume (20 ml) of elution buffer (0.02 M Tris‐HCl,
0.5 M NaCl, pH 7.5) and equilibration buffer. After the gradient, an additional 10 ml of
high salt buffer (0.02 M Tris‐HCl, 1 M NaCl, pH 7.5) was applied to the column to elute
all tightly bound protein. Fractions were assayed for antibacterial activity and lysozyme
as described above. Those exhibiting antibacterial activity were pooled and
concentrated by lyophilization and stored at ‐20C until needed.
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Anion exchange chromatography using Q Sepharose or DE Sepharose
Q Sepharose and DE Sepharose are beaded agarose matrices (Pharmacia, NJ).
Material was washed several times with equilibration buffer (0.02 M Tris‐HCl, 0.05 M
NaCl, pH 7.5) to remove the ethanol preservative and a column measuring 1.0 cm
diameter x 4.5 cm in length (bed volume of 3.8 ml) was prepared according to the
procedure described above for DE cellulose and run under similar conditions except
the flow rate was adjusted to 0.5 ml/min and 1 ml fractions were collected. Active
fractions were pooled, dialyzed, concentrated by freeze‐drying, and stored at ‐20C
until needed.
Heparin‐sepharose affinity chromatography
Heparin is a glycosaminoglycan which serves as an effective affinity binding and ion
exchange ligand for a wide range of bio‐molecules and has been shown to bind
enzymes/proteins that act on nucleic acids. Heparin‐Sepharose, a highly cross‐linked
agarose matrix (Pharmacia, NJ), was washed several times with equilibration buffer (0.1
M Tris, 0.01 M citric acid, 0.075 M NaCl, pH 7.5) to remove the ethanol and a column was
poured measuring 0.7 cm diameter x 2.5 cm in length (bed volume of 1 ml). The column
was washed with 10 ml of equilibration buffer and when the ionicity of the column eluant
was similar to that of the equilibration buffer the sample was applied to the column. The
flow rate was adjusted to 0.75 ml/min and 0.5 ml fractions were collected. Following the
application of the sample, the column was washed with equilibration buffer
(approximately 10 ml) until the OD280nm of fractions were the same as the equilibration
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buffer. Proteins bound to the column were then eluted with a linear NaCl gradient using
equal volumes (20 ml) of elution buffer (0.1 M Tris, 0.01 M citric acid, 2 M NaCl, pH 7.5)
and equilibration buffer. After the gradient, an additional 15 ml of high salt buffer (0.1 M
Tris, 0.01 M citric acid, 2 M NaCl, pH 7.5) was applied to the column to elute all tightly
bound protein. Fractions were assayed for antibacterial activity by the standard
microdilution growth assay. Those exhibiting antibacterial activity were pooled, dialyzed,
concentrated by freeze‐drying, and stored at ‐20C until needed.

SDS‐PAGE Analysis of Chromatography Fractions
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS‐PAGE) is a rapid
and reproducible way of analyzing proteins under reducing and non‐reducing
conditions, on the basis of their molecular size and mobility through gel matrix
(Laemmli 1970). It is also a more accurate and dependable method than gel filtration
for determining the molecular size of proteins/peptides of interest. Column fractions
were analyzed by SDS‐PAGE under reducing and non‐reducing conditions to determine
protein composition. Gels were either purchased commercially (gradient 10‐20% Tris‐
Tricine Criterion gels) (Bio‐Rad, CA), or poured in the laboratory (single percentage
7.5% and 10%). Samples were mixed in a 4:1 ratio with 5x sample buffer (with or
without 5% mercaptoethanol), and 30 µl of each sample loaded into individual wells.
Protein standards used as molecular weight markers consisted of a commercial
mixture of proteins (Bio‐Rad, CA) that included myosin (200 kDa), ‐galactosidase
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(116.3 kDA), phosphorylase B (97.4 kDa), BSA (66.3 kDa), ovalbumin (45 kDa), carbonic
anhydrase (31 kDa), soybean trypsin inhibitor (21.5 kDa), lysozyme (14.4 kDa) and
aprotinin (6.5 kDa). Criterion gels (Bio‐Rad, CA) were electrophoresed at room
temperature at 200V (0.06 Amps) using chilled 1X Running buffer containing 0.1% SDS.
Electrophoresis was stopped when the dye front migrated to the bottom of the gel.
The gels were stained with Coomassie R‐250 for 10 min with gentle agitation and
destained for 24 hours in a solution containing 37.5% methanol, 10% acetic acid and
2.5% glycerol. Gels were then dried in a Model 450 gel dryer (Bio‐Rad, CA), following
manufacturer’s instructions.

Western Blot
To identify whether proteins contained in active samples were histones/histone
fragments, samples were analyzed in Western blots using heterologous antisera raised
against a variety of human histone proteins. Western blots were set up as follows:
following SDS‐PAGE of samples, gels were equilibrated in transfer buffer for 15‐20 min.
Nitrocellulose membrane (Bio‐Rad, CA) was first equilibrated with 100% methanol for 5
min, then added to the container with electrophoresed gel to equilibrate in transfer
buffer for an additional 15 min. A "sandwich" of the gel and nitrocellulose membrane (in
close contact and with no trapped air bubbles) between filter paper and sponge pads
was carefully put together. Proteins from the gel were transferred to the membrane
through electro‐blotting by electrophoresing the sandwich for 1 hr at 100 volts.
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Following transfer, the membrane was separated from the gel and immersed in
blocking solution and incubated with gentle shaking for 90 min at room temperature
followed by overnight incubation at 10oC. The blocking step was to ensure that all
"sticky" sites on the membrane were blocked with milk protein contained in the
blocking solution. After overnight incubation the blocking solution was decanted and
the membrane washed with diluent buffer with gentle agitation, for 5 ‐ 10 min at RT.
The wash buffer was discarded and the membrane washed once more with wash buffer.
Primary antibody reagent (10 ml) was added to the membrane and incubated at room
temperature for 3 hr after which the primary antibody was removed and unbound
antibody washed away from the membrane by adding more wash diluent buffer and
incubating at RT for additional 20 min. This wash step was repeated once more. The
wash buffer was discarded and the secondary antibody conjugate reagent (10 ml) was
added and incubated at room temperature for 1 hr. After incubation, the secondary
antibody reagent was decanted, and the membrane washed in buffer to wash away all
unbound conjugate from the blot. The wash step was achieved by gently agitating the
membrane for another 10 min at RT. The membrane was washed twice more. To
develop the blot for visualization of reactive protein bands the membrane was
immersed in 10 ml of HRP color development solution (Bio‐Rad, CA) until color
development was complete (approximately 2 ‐ 5 min). Color development was stopped
by immersing the membrane in distilled water for 5 min. Forceps were used to handle
the membrane, placing it between two filter pads until dry and then wrapped in foil
paper for storage at ‐20°C.
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Correlation of Antibacterial Activity with Specific Protein Bands
To correlate antimicrobial activity detected in samples with a specific protein,
active fractions were subjected to polyacrylamide gel electrophoresis under acid
conditions, and the gel containing separated proteins/peptides was overlaid on an
agarose seeded with Planococcus citreus (the underlay). The overlay permits protein
bands to diffuse into the agarose and inhibit the growth of the bacterial lawn.
Acid‐urea (AU) electrophoresis was performed using 12.5% acid‐urea gels which
were pre‐run for 1 hr with reversed polarity at 30mA/120V using 5% acetic acid in both
upper and lower buffer chambers. The running buffer was discarded and the gel
assembly rinsed with ddH2O and reassembled with fresh buffer. Test samples were
diluted in 5% acetic acid, mixed with 3x sample buffer and immediately loaded into
wells of two gels in identical order and run as before with fresh 5% acetic acid for 50
min at 80‐100V at reverse polarity. After the gels were removed from the apparatus,
one gel was stained with Laemmli coomassie stain while the other was rinsed three
times with rinse buffer (changing rinse buffer every 5 min).
The washed gel was placed on an agarose underlay and the plates incubated at
30°C for 3 hr to permit diffusion of the protein/peptide bands into the underlay
containing the target organism. The underlay was prepared by adding 100 l of a
standardized suspension of Planococcus citreus (approximately 106 organisms/ml) to
10 ml of molten (44C) 1% agarose, and allowing the mixture to solidify in a petri dish
(100 x 15 mm square with 13 mm grid) at room temperature. Using the sterile tip of a
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3mm diameter template cutter, two wells were punched into the agar along the
periphery of the plate. 5 l each of positive control, HNP1 (25 µg/ml) and negative
control (3.2% saline solution) were then added to each respective well. Following
incubation the gel was removed and stained (to determine efficiency of transfer) and
the surface of each plate was overlaid with 10 ml of molten overlay nutrient medium
necessary for bacterial growth (artificial sea water complete broth in 1% agar). Once
the overlay had solidified, the plates were inverted and incubated at 30C for 24 hr.
The plates were examined for clear zones of inhibition of bacterial growth. The
bacterial lawn appeared as a uniform turbid background. The plate was stained with
the modified coomassie stain and photographed using a digital camera (Sony).

Amino Acid Sequence Analysis of Lysate Proteins/Peptides
Amino acid sequence data for specific proteins/peptides identified in lysate
fractions was obtained either by Edman degradation (yielding N‐terminal sequence) or
by LC‐MS/MS analysis of trypsin digests. Samples for analysis were lysate fractions in
which antibacterial activity had been detected either by the agar diffusion assay or the
standard microdilution growth assay with activity further correlated to specific protein
band(s) by AU gel overlay assays.
Samples for N‐terminal sequence analysis by Edman degradation were prepared as
follows. Briefly, samples were subjected to SDS‐PAGE, gels were equilibrated in
transfer buffer containing 10% methanol for five minutes, and placed in a sandwich
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containing the PVDF membrane in direct contact with the gel, and insulated with filter
paper and fiber pads to ensure proper transfer. The sandwich was electrophoresed at
100V for 1hr (Criterion Gel System, Bio‐Rad) and the membrane was removed from
the sandwich and stained for 1 min in 0.02% Coomassie R‐250 solution containing 40%
methanol. It was then placed in destain solution of 40% methanol for up to 1 min and
washed in distilled water for 3‐5 min with at least three changes of water. Forceps
were used to handle the membrane, placing it between two filter pads until dry and
then wrapped in foil paper before mailing to the protein core facility (ICBR, University
of Florida) for N‐terminal sequence analysis. Protein bands that corresponded to
those that (1) reacted in a Western blot with antisera to specific histones and/or (2)
demonstrated antibacterial activity in acid urea overlay assays were chosen for
sequencing.
Samples for trypsin digestion and LC‐MS/MS analysis were prepared by subjecting
them to SDS‐PAGE analysis then gels were stained for 1 hour with Coomassie stain
(New England Biolabs, MA), followed by destaining with water for 30 min. The bands
selected for analysis were excised with a scalpel blade and placed in an eppendorf
tube and stored at ‐20 °C until shipped in dry ice to the protein core facility (ICBR,
University of Florida) for tryptic digestion and LC‐MS/MS analysis.
The trypsin digested samples were injected onto a capillary trap (LC Packings,
PepMap) and desalted for 5 min with a flow rate 3 µl/min of 0.1% v/v acetic acid. The
samples were loaded onto an LC Packing® C18 Pep Map nanoflow HPLC column. The
elution gradient of the HPLC column started at 3% solvent A, 97% solvent B and
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finished at 60% solvent A, 40% solvent B for 30 min for protein identification. Solvent A
consisted of 0.1% v/v acetic acid, 3% v/v ACN, and 96.9% v/v H2O. Solvent B consisted
of 0.1% v/v acetic acid, 96.9% v/v ACN, and 3% v/v H2O.LC‐MS/MS analysis was carried
out on a LTQ Orbitrap XL mass spectrometer (Fisher Scientific, GA). The ion spray
voltage was set to 2200 V. Full MS scans were acquired with a resolution of 60,000 in
the orbitrap from m/z 300–2000. The five most intense ions were fragmented by
collision induced dissociation (CID). Dynamic exclusion was set to 60 seconds.
Protein search algorithm
Data from all MS/MS samples were analyzed using Mascot (Matrix Science,
London, UK; version 2.2.2). Mascot was set up to search both NCBI and
NCBI_chondichthes databases assuming trypsin digestion. Mascot was searched with a
fragment ion mass tolerance of 10 ppm and a parent ion tolerance of 10 ppm.
Iodoacetamide derivative of Cys, deamidation of Asn and Gln, oxidation of Met, are
specified in Mascot as variable modifications. Scaffold (version Scaffold‐03‐00‐04,
Proteome Software Inc., Portland, OR) was used to validate MS/MS based peptide and
protein identifications. Peptide identifications are accepted if they could be
established at greater than 95.0% probability as specified by the Peptide Prophet
algorithm. Protein identifications are accepted if they can be established at greater
than 99.0% probability and contain at least two identified unique peptides. Protein
probabilities were assigned by the Protein Prophet algorithm.
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IV. RESULTS

Composition of Leukocyte Fraction of Shark Peripheral Blood
Structural morphology of cell types
Since the aim of the study is to identify proteins or peptides associated with
antibacterial activity of leukocytes, it was essential to confirm that lysates made from
leukocytes were made up of all leukocyte types. Figure 1a through 1e show different cell
types found in nurse shark peripheral blood leukocytes. Two major granulocytic cells
are present. One is eosinophil‐like, a granulocyte with deeply staining eosinophilic intra‐
cytoplasmic granules with a lobed nucleus (Figure 1a). These cells are similar in staining
properties to mammalian eosinophils. The second type of granulocytic cell is the
neutrophil‐like granulocyte, characterized by an eccentric, usually bi‐lobed, nucleus
surrounded by cytoplasm containing granules (Figure 1b), distinctly different from those
of the eosinophilic granulocyte. Four types of mononuclear cells are present. The
monocyte‐macrophage cells are mononuclear and lack distinct granules. The nucleus is
large and usually no more than half of the cell volume (Figure 1c). The second
mononuclear cell is the lymphocyte‐like cell (Figure 1d), which is similar to a mammalian
lymphocyte with a spheroidal nucleus occupying much of the cell volume, and
surrounded by a narrow rim of cytoplasm. The third cell type is the thrombocyte, which
usually appears discoidal with a single, large, centrally placed, oval nucleus (Figure 1e).
However, depending on how the blood is processed, thrombocytes may assume several
distinct shapes (e.g., spiked, spindle or fragmented). Another cell type occasionally
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Differential count of cell types
Differential leukocyte counts (carried out in duplicate) of peripheral whole blood, from
one individual, yielded relative numbers of the cell types. These are shown in Table 1,
expressed as percentage, with 200 leukocytes counted per slide (average of three
slides). A normal differential leukocyte count of human peripheral blood, expressed as
percentage, is provided for comparison (Altman et al. 1961).
Table 1 Relative Numbers of Different Leukocytes in Nurse Shark (present study)
and Human Peripheral Blood
Nurse Shark Peripheral Blood

Human Peripheral Blood

Cell Type

%

Cell Type

%

Neutrophilic granulocyte

32.5

Neutrophilic granulocyte

59

Eosinophil‐like

11.5

Eosinophil

2.7

Monocyte‐macrophage

2.5

Monocyte‐macrophage

4

Lymphocyte‐like

40

Lymphocyte

34

Basophil

0

Basophil

0.5

Thrombocyte

13.5

Thrombocyte

n/a

Detection and Quantitation of Antibacterial Activity of Leukocyte Lysates
Lysates were prepared as stated in the materials and methods. Protein
concentration of lysate preparations ranged from 2‐8 mg/ml, depending on the number
of leukocytes harvested and the procedure used to disrupt cells. Initial screening of
crude lysates for lysozyme and antibacterial activity was performed using the lysoplate
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and agar diffusion methods, respectively (Osserman et al. 1966; Lehrer et al. 1991;
Manchenko 1994). Antibacterial activity against Planococcus citreus was detected in all
lysates tested, except for lysate sample #3 at 25°C (Table 2).

Table 2
Lysates

Quantitation of Antibacterial Activity of Different Preparations of Leukocyte

Antibacterial Activity in
AU

Lysate sample
Leukocyte lysate sample

At 30°C
35

At 25°C
25

Leukocyte lysate sample

50

40

Leukocyte lysate sample

5

0

Leukocyte lysate sample

40

15

Leukocyte lysate sample

45

30

Leukocyte lysate sample

80

60

#1
#2
#3
#4
#5
#6
NOTE: Activity Units (AU) represents the average of duplicate readings at each temperature

The modified radial diffusion assay supplemented with sea water complete medium
(SCM) was semi‐quantitative and antibacterial activity was estimated by measurement
of the diameter of the zones of inhibition as seen in Figure 2. The level of antibacterial
activity varied from preparation to preparation as expected, because lysates were
prepared from different blood samples, collected at different times. Antibacterial
assays carried out at 30°C showed larger and more pronounced zones of inhibition than
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Figure 2 Re
epresentative raadial diffusion assay
a
plates. Anntibacterial activvity is seen as a cclear area (arrow
w)
around wellss (wells are 3mm
m in diameter). Duplicate
D
samplees (10 l) of six ddifferent lysate p
preparations (1‐‐6 in
figure) were individually add
ded to wells. Duplicate plates w
were incubated (aa) at 30°C and (b
b) at 25°C. Diameter
a
24 h incubaation and antibaacterial activity eexpressed in acttivity units calculated
of the zones was measured after
according to the formula in materials
m
and methods (Table 2 ).

When lysaates were prrepared from
m different bbleeds, and antibacteriaal activity waas
measured
m
at 25°C and 30
0°C, it was se
een that acttivity, as sho
own by zoness of inhibitio
on
measured
m
(Figure 2a, arro
ow), was con
nsistently hiigher when p
plates were incubated aat
30°C as opposed to 25°C..
When asssaying for lyssozyme‐like activity usinng the lysoplate assay, reetention of
activity was in
nconsistent and was affe
ected by thee method ussed to prepare the extracts,
i.e., mechaniccal shearing,, homogenizzation versuss sonication. When the method of
preparation was
w mechanical shearingg or glass hoomogenizatio
on, the lysozzyme‐like acctivity
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was detected. However, when the method of preparation was sonication, the
lysozyme‐like activity could not be detected by the lysoplate assay.
Development of a microdilution growth assay
The radial diffusion assay was effective as an initial screening method, however, a more
sensitive and accurate assay, such as a microdilution growth assay (not currently
available for sharks) was necessary.
In order to develop this assay, optimal conditions (pH, salinity, incubation
temperature, etc.) for growth of the target organism, P. citreus, and for antibacterial
activity (growth inhibition) was determined.
(1) Growth curve of P. citreus in SCM
Growth of Planococcus citreus in SCM was monitored by measuring OD at 570 and
630 nm in micro‐well plates over a period of 24h at 30°C (Figure 3). The culture
reached mid‐log phase in 10 hours. No significant difference was noted between OD
readings taken at 570 or 630 nm, and subsequent experiments measuring bacterial
growth were read at 570 nm. Ten h cultures (growing exponentially) were used as
target cell inoculum for all future microdilution growth assays.
(2) Effect of pH and salinity on P. citreus growth
Microdilution growth assays were set up in SCM medium adjusted to varying pH
(4.0, 5.5, 6.5, 7.5 and 8.5) and salinity (0.3M, 0.4M, 0.5M, 0.6M NaCl). Since
previous radial diffusion assays had shown enhanced antibacterial activity at 30°C,
microdilution growth assays were incubated at 30°C. The data shown in Table 3 are
represented by OD570nm. Growth at pH 4.0, 5.5 and 6.5 was minimal. Growth did
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occur at pH 7.5 and 8.5. For the standard assay, a pH of 7.5 was chosen as it is closer
to physiological pH for shark leukocytes. Planococcus citreus grew at identical rates
in SCM adjusted to a final NaCl concentration of 0.3M, 0.4M, 0.5 and 0.6M NaCl.
Since the concentration of NaCl in SCM is normally 0.5M, all assays were performed
using SCM without adjusting salt concentration.
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Figure 3
Growth of Planococcus citreus in Sea water Complete Medium. A 10 h culture (50l) of P. citreus in sea
water complete medium (SCM) was inoculated into 50 l fresh 2x SCM (salt concentration was unchanged (1x) in
double strength media). The culture was incubated at 30°C and OD read at 2h intervals in a Dynex ELISA reader at
wavelength 570 and 630 nm. Each point represents an average OD reading of samples from triplicate cultures. Error
bars fall within plot points and are not visible.
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Table 3
pH of
media
4.0
5.5
6.5
7.5
8.5

Effect of pH and Salinity on Growth of Planococcus citreus

0h
0.004
0.004
0.003
0.007
0.004

OD
12 h
0.013
0.021
0.055
0.326
0.280

(a)

NaCl concentration
of media
0.3M
0.4M
0.5M
0.6M

0h
0.003
0.004
0.009
0.010

OD
12 h
0.307
0.285
0.321
0.312

(b)

NOTE: A 10 h culture (100l) of P. citreus in SCM was inoculated into 75 l fresh 2x SCM, adjusted to (a)
different pH and (b) different salinity. The culture was incubated at 30°C and OD 570nm read at 2h
intervals in a Dynex ELISA reader. Each point represents an average OD reading of samples from
duplicate cultures.

(3) Determination of optimal temperature for P. citreus growth and antibacterial
activity of lysate for microdilution growth assay
Optimal incubation temperature was determined by monitoring growth of P.
citreus with and without the lysate at 30°C and 25°C (Table 4). Thirty degree celsius
was optimal for growth of the target organism and maximal for antibacterial activity
of the lysate.
Table 4 Effect of Temperature on P. citreus Growth and Antibacterial Activity of
Leukocyte Lysate
Incubation
temperature
25°C
30°C

0h
0.013
0.011

OD
12 h
0.036
0.119

25°C + lysate
30°C + lysate

0.032
0.032

0.052
0.048

NOTE: Planococcus citreus cultures were incubated with and without lysate and incubated at 25°C and
30°C. Bacterial growth was measured by taking OD 570nm readings at 2h intervals in a Dynex ELISA. Each
reading represents an average OD reading from triplicate cultures.
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(4) Determination of optimal target cell density for microdilution growth assay
The optimal concentration of Planococcus citreus for the assay was determined
by performing the assay using two different concentrations of bacteria; 1x105
CFU/ml and 2.5x104 CFU/ml. The effect of crude lysate, concentrated four‐fold, on
Planococcus citreus growth was followed over a 24 hr period at 30°C. At 10 hours no
significant effect (antibacterial) on growth of P. citreus was noted at a cell density of
1x105 CFU/ml (Figure 4). Lack of activity may be caused by excessive cell density,
masking any inhibitory effect. Antibacterial activity was measurable as inhibition of
growth after 4 hours, at a cell density of 2.5x104 CFU/ml. This was the density of
target cells used for all future assays.

Optical Density (570nm)

1

1x105 cfu/ml
1x105 cfu/ml+LL (4x)

0.1

2.5x104 cfu/ml
2.5x104 cfu/ml + LL (4x)

0.01

0.001
0
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6

8 10 12 14 16 18 20 22 24
Time (h)

Figure 4
Antibacterial effect of leukocyte lysates on growth of Planococcus citreus at different target cell
densities. A four‐fold concentration of the crude extract was added to different densities of P. citreus (1x105 CFU/ml
and 2.5x104 CFU/ml) and bacterial growth at 30°C was compared to corresponding control culture consisting of P.
citreus in the absence of lysate. Each reading represents an average OD 570nm of samples from triplicate cultures
(measured at 2 h intervals for 24 h).
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(5) Sensitivity of microdilution growth assay
The minimum threshold level of antibacterial activity detectable (in crude lysate)
by micro‐titration was determined by measuring the antibacterial effect of different
concentrations of lysate on growth of P. citreus. A crude lysate (1x), a two‐fold
diluted (0.5x) sample and a four‐fold concentrated sample of the same lysate (4x)
were compared for growth inhibition (Figure 5). There was no appreciable difference
in bacterial growth when the culture with lysate, diluted two‐fold (0.5x), was
compared to the control culture. However, inhibition of bacterial growth was shown
by the crude lysate (1x) after 10 hours, and by the 4x concentrated lysate by 4 hours.
Results indicate that the antibacterial activity of crude lysates can be measured by
the assay after 10 hours of incubation. The end point for the standard assay was set
for 12 hours (Figure 5b).
(6) Establishment of standardized microdilution growth assay
On the basis of the results above, the microdilution growth assay was
standardized as follows. Each assay consisted of 50 l of test sample, 75 l of 2x
SCM and 100 l standardized P. citreus inoculum (2.5x104 CFU/ml, final
concentration). The SCM contained 0.5M NaCl and pH was adjusted to 7.5. Assays
were set up in triplicate and incubated at 30°C for up to 12 hours. Wells were read at
OD 570nm.
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Figure 5
Antibacterial activity of diluted and concentrated samples of crude leukocyte lysate. (a) A two‐
fold diluted sample, a crude lysate, and a four‐fold concentrated sample of the same LL was added to P. citreus
4
at a cell density of 2.5x10 CFU/ml and bacterial growth at 30°C was compared to corresponding control cultures
consisting of P. citreus in the absence of lysate. Each point represents an average OD of samples from triplicate
cultures. (b) Percent growth inhibition of a two‐fold diluted sample, a crude lysate, and a four‐fold concentrated
sample of the same LL calculated at 12 h.
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Application of standard assay to titrate antibacterial activity in lysates
To quantify the level of antibacterial activity present in samples, microdilution
growth assays were set up using three different lysate preparations (lysate preps
were from different blood samples, drawn at different times from different animals).
Two‐fold serial dilutions were made of each lysate in SCM and assayed for
antibacterial activity, which was measured and expressed as percent growth
inhibition calculated according to the formula:
% Inhibition = Final OD570nm P. citreus control – Final OD570nm of test sample x 100
Final OD570nm P. citreus control

where ‘test sample’ is P. citreus with test leukocyte lysate (LL).
Figure 6 shows that with increasing dilution of test lysate a corresponding
decrease in antibacterial activity (measured as percent inhibition of P. citreus
growth) is noted. The assay has sufficient sensitivity to detect antibacterial activity
in crude lysate samples containing varying levels of antibacterial activity. Lysate
sample, LL‐1S was the least active lysate, while LL‐3S showed the most antibacterial
activity. The antibacterial activity titer of a lysate was taken as the inverse of the
highest dilution that inhibited growth of P. citreus. Thus the antibacterial activity
titer of LL‐1S, 2S and 3S is 4, 8 and greater than 16, respectively. However, the
growth inhibition detected below 20% may not be meaningful after an eight‐fold
dilution.

64

% inhibition of P.c.
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0
1
1:1
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1:2

41:4

81:8
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Figure 6
Variation in the antibacterial activity of different lysate preparations from different bleeds. Serial two‐
fold dilutions of lysates, LL‐1S, LL‐2S and LL‐3S were made in 2x SCM. The assay was incubated at 30°C and assay end
point OD 570nm readings taken at 12 h in a Dynex ELISA reader. Each bar represents percent inhibition calculated from
mean OD of duplicate cultures and compared to the control (P. citreus in the absence of lysate).

Fractionation of Cell Lysates and Protein Analysis of Active Fractions
The initial screening of lysates for antibacterial activity was by the agar diffusion
assay method. Lysates prepared by mechanical shearing, homogenization or sonication
were fractionated by ion‐exchange chromatography and several different permutations
of chromatographic separation were employed. Column fractions were assayed for
antibacterial and lysozyme activity. Fractions exhibiting antibacterial activity were
further analyzed by SDS‐PAGE analysis to determine protein composition and select
protein bands were selected for amino acid sequence analysis.
Protocol I: DE Cellulose‐Heparin
Protocol I consisted of a two step fractionation on DE cellulose, followed by affinity
chromatography (Figure 7‐9). Profiles of ion‐exchange chromatography are illustrated in

65

Figures 7 and 8. Briefly, a lysate prepared by mechanical shearing using a glass
homogenizer was concentrated four‐fold by ultra‐filtration and applied to the first DE‐52
cellulose column. Fractions were assayed for lysozyme and antibacterial activity. Most
of the lysozyme activity was recovered in the pre‐gradient fractions along with some
antibacterial activity (Figure 7). Some lysozyme activity was also recovered in early post
gradient fractions. Most of the antibacterial activity, however, was present in the post‐
gradient fractions (Figure 7). The active fractions were pooled into 4 distinct pools
consisting of the following fractions: Pool I (6‐12), Pool II (70‐77), Pool III (78‐87), Pool IV
(103‐115) and Pool V (116‐125). Pool I was concentrated by ultra‐filtration and applied
to a second DE cellulose column run under similar conditions to separate lysozyme from
antibacterial activity. A similar elution profile to that of the first column was obtained
(Figure 8) with lysozyme present in pre‐ and early post‐gradient fractions, and with
antibacterial activity separated and found in the later post‐gradient fractions.
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Figure 7
Protocol I: Fractionation of leukocyte lysate on DE Cellulose. Crude lysate (2.5 ml) mixed with an equal
volume of equilibration buffer was applied to DE‐52 column (1.0 x 4.5 cm) equilibrated with 0.02M Tris‐HCl, pH 7.5.
Fractions (0.8 ml) were collected at a flow rate of 0.7 ml/min at 25C. Bound proteins were eluted from the column
with a linear NaCl gradient, up to 0.9M NaCl. Antibacterial (blue bars) and lysozyme activity (green bars) were
measured by agar diffusion for every other fraction and recorded as activity units (for details see Methods).
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Figure 8 Protocol I: Fractionation of Pool I from the first DE Cellulose column. Crude lysate (2 ml) mixed with an
equal volume of equilibration buffer was applied to DE‐52 column (1.0 x 4.5 cm) equilibrated with 0.02M Tris‐HCl, pH
7.5. Fractions (0.8 ml) were collected at a flow rate of 0.7 ml/min at 25C. Bound proteins were eluted from the
column with a linear NaCl gradient, up to 0.9M NaCl. Antibacterial (blue bars) and lysozyme activity (green bars) was
measured by agar diffusion for every other fraction and recorded as activity units (for details see Methods).

Active fractions of the second column were pooled into four pools: Pool I (6‐12),
Pool II (50‐55), Pool III (84‐89) and Pool IV (90‐93). Pool IV and Pool III, containing most
of the antibacterial activity from the first and second chromatographic separations,
respectively, were combined and dialyzed against the equilibration buffer ( 100mM Tris‐
HCl, 10mM citric acid, 225mM NaCl, pH 7.4) used for heparin affinity chromatography.
Ten ml of the combined pool was applied to a heparin column (Figure 9a). Bound
proteins were eluted by batch elution using buffers varying in salt concentration from
0.225M to 1.5M NaCl. Fractions were screened for antibacterial activity and active
fractions were pooled (Fractions 79‐89), concentrated five‐fold and further analyzed by
SDS‐PAGE analysis (Figure 9b). Proteins were subsequently transferred to a PVDF
membrane for sequence analysis. An SDS‐PAGE gel stained with coomassie blue
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revealed two distinct protein bands between 6 and 14 kDa (Figure 9b). Protein bands
were subjected to Edman Degradation for N‐terminal protein sequencing (performed by
University of Florida Protein Core). The upper band (~14 kDa) generated an N‐terminal
sequence of 14 residues with homology to teleost histone, H2B (see Table 5 below). The
lower band (~6 kDa) generated an N‐terminal sequence of 14 residues with homology to
teleost histone, H2A (see Table 5 below). Pool I, which contained only lysozyme activity,
from the second chromatographic separation was similarly loaded onto a heparin
affinity column, but no bound protein was eluted (profile not shown).
Protocol IIA: DE Sepharose‐glass homogenized lysate
An alternative fractionation protocol consisted of a single fractionation step on DE –
Sepharose. A leukocyte lysate was prepared by mechanical shearing and concentrated
ten‐fold by using a combination of vacuum centrifugation and ultra‐filtration
(membrane cut‐off MWCO, 3.5kDa). The sample (800 l) was dialyzed against the
column equilibration buffer (0.02M Tris‐HCl, pH 7.5) and applied to a DE Sepharose
column. Bound proteins were eluted with a linear gradient, up to 0.9M NaCl (Figure
10a). Pre‐ and post‐gradient fractions showing peak antibacterial activity were pooled.
Pre‐gradient and early post‐gradient fractions, Pool I (9‐19) and Pool III (61‐75)
contained antibacterial, along with lysozyme activity which was absent from the later
post‐gradient fractions, Pool IV (95‐107) and Pool V (108‐121) that contained only
antibacterial activity. Control assays testing elution buffers corresponding to the salt
concentration at the end of the gradient showed inhibition of growth. Therefore, Pool V
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Pool IV (fractions 95‐107) was concentrated ten‐fold by ultra‐filtration (MWCO 3.5kDa).
Pool IV was further analyzed for protein composition using SDS‐PAGE analysis (Figure
10b). Proteins from the gel were subsequently transferred to a PVDF membrane for
sequence analysis. The lowest band (~6 kDa) was subjected to Edman Degradation for
protein sequencing (University of Florida Protein Core). The protein band generated an
N‐terminal amino acid sequence of 12 residues with homology to teleost and
mammalian histone, H2A (see Table 5 below). The upper bands were also sequenced
but yielded amino acid sequences with no significant homology.
Table 5 N‐terminal Amino Acid Sequence of Proteins Isolated from Shark Leukocyte
Lysate Analyzed by Edman Degradation
Sample

Band

Sequence

ID

Pool II‐ Heparin Affinity
(Protocol I)

Upper

KGAKKRSRSRKEXY

Histone H2B

Pool II ‐Heparin Affinity
(Protocol I)

Lower

SIAISRSYRAGLQF

Histone H2A

Pool IV‐DE Sepharose (Protocol
IIA)

Lower

SRSERAGLQFQK

Histone H2A
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Figure 10 Protocol IIA: Fractionation of leukocyte lysate on DE Sepharose and SDS‐PAGE analysis. (a) Crude lysate
(0.8 ml) mixed with an equal volume of equilibration buffer was applied to DE Sepharose column (1.0 x 4.5 cm)
equilibrated with 0.02M Tris‐HCl, pH 7.5. Fractions (0.5 ml) were collected at a flow rate of 0.5 ml/min at 25C.
Bound proteins were eluted with a linear NaCl gradient, up to 0.9M NaCl. Antibacterial (blue bars) and lysozyme
activity (green bars) was measured by agar diffusion for every other fraction and recorded as activity units (for details
see Methods). Post‐gradient fractions (95‐107, pool IV) were pooled, concentrated ten‐fold and analyzed by SDS‐
PAGE. (b) Lane 1 contained Pool IV. Lane 2 contained sample buffer only. Molecular weight standard (MWS) (Bio‐Rad
Broad Range) was run in lane # 3.
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Fractionation of Cell Lysates and Correlation of Antibacterial Activity with Specific
Protein Bands
Since histone fragments and other types of protein fragments and peptides have
been shown in other species to have antibacterial activity, experiments were performed
to determine whether antibacterial activity could be correlated to specific protein
band(s) and to show whether the shark histone fragments identified were antibacterial.
Thus, subsequent fractionation was carried out employing similar chromatographic
conditions (see above) with minor modifications to buffers. Also fractions were
screened for antibacterial activity using the standard microdilution growth assays in
place of the agar diffusion assay. In addition, lysates were prepared by sonication rather
than mechanical shearing and/or homogenization, since a higher level of activity was
recovered in the sonicated lysate. Several DE Sepharose columns were run either singly
or in series to fractionate the leukocyte lysates. To correlate antimicrobial activity with a
specific protein/peptide, active fractions and/or pools were subjected to the acid‐urea
gel overlay protocol.
Protocol IIB: DE Sepharose‐sonicate lysate I
A leukocyte lysate prepared by sonication of leukocytes and concentrated five‐fold
by lyophilization, was reconstituted in 0.5 ml ddH2O and applied to a DE Sepharose
column. Figure 11 shows the chromatographic profile yielding two major protein peaks,
a pre‐gradient and post‐gradient peak. Every other fraction was assayed for
antibacterial activity using the microdilution growth assay and antibacterial activity was
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present in both pre‐gradient and post‐gradient fractions. The peak activity fractions
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Figure 11 Protocol IIB: Fractionation of lysate on DE Sepharose column. A five‐fold concentrated crude lysate (0.5
ml) mixed with equilibration buffer (0.3 ml) was applied to DE Sepharose column (1.0 x 4.5 cm) equilibrated with
0.02M Tris‐HCl, 0.05M NaCl, pH 7.5. Fractions (1 ml) were collected at a flow rate of 1 ml/min at 25C. Bound
proteins were eluted from the column with a linear NaCl gradient, up to 0.9M NaCl.

Fractions 4‐9 were pooled (Pool I), concentrated ten‐fold by lyophilization, and
subjected to acid‐urea gel electrophoresis and analyzed for antibacterial activity by
applying to a lawn of target organisms (acid‐urea overlay). Distinct zones of inhibition
were seen in the seeded lawn (Figure 12a) corresponding to the position of protein
bands in the AU transfer gel. The acid‐urea transfer gel stained with coomassie blue
(Figure 12b), shows residual protein remaining after transfer of the ‘active’ protein to
the agar overlay plate seeded with P. citreus. The position of residual protein bands
correlates with the zone of inhibition noted on acid‐urea overlay agar plate.
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Figure 12 Acid‐‐Urea PAGE anaalysis of concenttrated Pool I (Prrotocol IIB). (a) Concentrated Pool I, from Proto
ocol IIB
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Protocol IIC‐1
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Fiigure 13 SDSS‐PAGE Analysis of Pool I from DE Sepharo
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electrophoresis, were analyzed for antibacterial activity by applying to a lawn of P.
citreus (acid‐urea overlay). Distinct zones of inhibition were seen in the seeded lawn for
pools I, II and IV, although growth of P. citreus was sparse. Zones of growth inhibition
are shown in Figure 16. A tandem gel run simultaneously as the gel used to overlay the
seeded agar was stained with coomassie blue (Figure 16a) to show position of protein
bands occurring on the gel. LC‐MS/MS analysis could not be performed on these
samples because of contamination of the pools resulting from loss of refrigeration upon
storage.
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Figure 14 Protocol IIC‐1: Fractionation of lysate on DE Sepharose column. Concentrated crude lysate (0.4 ml)
mixed with equilibration buffer (0.1 ml) was applied to DE Sepharose column (1.0 x 4.5 cm) equilibrated with 0.02M
Tris‐HCl, 0.05M NaCl, pH 7.5. Fractions (1 ml) were collected at a flow rate of 1 ml/min at 25C. Bound proteins were
eluted from the column with a linear NaCl gradient, up to 0.9M NaCl. Antibacterial activity (blue bars) was measured
by microdilution growth assays for all fractions tested and recorded as percent growth inhibition (for details see
Methods).
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concentrated fifty‐fold by lyophilization and reconstituted in ddH2O. This sample was
applied to a second DE Sepharose column run under similar conditions. Antibacterial
activity was recovered post‐gradient, with an increasing NaCl gradient (Figure 17).
Although there is antibacterial activity, it is at a low level (below 20%), so it is difficult to
distinguish the actual level of activity with these fractions that elute with high salt
concentration. Peak activity fractions were pooled, lyophilized and reconstituted in
ddH2O and analyzed by SDS‐PAGE and acid‐urea gel electrophoresis. The lawn of target
organism showed no zones of growth inhibition within the area subjected to acid‐urea
gel overlay, although a zone of inhibition was noted around the control antimicrobial
peptide, HNP1 (a β‐defensin).
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Figure 17 Protocol IIC‐1: Fractionation of Pool IV from first DE Sepharose column. Pool IV (0.5 ml) mixed with an
equal volume of equilibration buffer was applied to a second DE Sepharose column (2.5 x 4.5 cm) equilibrated with
0.02M Tris‐HCl, 0.05M NaCl, pH 7.5. Fractions (1 ml) were collected at a flow rate of 1 ml/min at 25C. Bound
proteins were eluted from the column with a linear NaCl gradient, up to 0.9M NaCl. Antibacterial activity (blue bars)
was measured by microdilution growth assay for all fractions tested and recorded as percent growth inhibition (for
details see Methods).
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Protocol IIC‐2: DE Sepharose‐sonicated lysate III
To improve separation and recovery of antibacterial activity the protocol for ion
exchange chromatography was modified by the application of a step‐wise elution
gradient. A leukocyte lysate concentrated five‐fold by lyophilization and reconstituted in
1 ml ddH2O was applied to a DE Sepharose column and eluted with a two step linear
NaCl gradient (Gradient 1‐0.05M NaCl to 0.5M NaCl; Gradient 2‐ 0.5M NaCl to 1.0M
NaCl). The chromatographic profile (Figure 18) shows four protein peaks, a pre‐gradient
and three post‐gradient peaks. Fractions were assayed for antibacterial activity using
the agar diffusion assay and antibacterial activity was present in the pre‐gradient and
post‐gradient peak fractions. The fractions showing high antibacterial activity were
further analyzed for protein composition by SDS‐PAGE (Figure 19).
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Figure 18
Protocol IIC‐2: Fractionation of lysate on DE Sepharose column. Concentrated crude lysate (0.7 ml)
mixed with equilibration buffer (0.3 ml) was applied to DE Sepharose column (2.5 x 4.5 cm) equilibrated with 0.02M
Tris‐HCl, 0.05M NaCl, pH 7.5. Fractions (1 ml) were collected at a flow rate of 1 ml/min at 25C. Bound proteins were
eluted from the column with a step‐wise NaCl gradient (Gradient 1‐0.5M NaCl; Gradient 2‐ 1.0M NaCl). Antibacterial
activity (blue bars) was measured by agar diffusion assay for all fractions tested and recorded as activity units (for
details see Methods).
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Table 6 Internal Amino Acid Sequence Analysis of Proteins Isolated from Shark
Leukocyte Lysates Analyzed by LC‐MS/MS
Sample

Band

Sequence

ID

Pool I‐DE Sepharose (Protocol IIB)

Band 1

TITLQVEPSDTIENVK

Polyubiquitin

IQDKEGIPPDQQR
KSTLHLVLR
Pool I‐DE Sepharose (Protocol IIB)

Band 1

LIFAGK

Ubiquitin

Pool III‐DE Sepharose (Protocol IIC‐2)

Band 1

FESNFNTQATNR

Chain A, HEWL

NTDGSTDYGILQINSR

Western Blot Analysis
Western blot analysis of pools was performed to determine whether histones and
lysozyme could be detected using heterologous antisera such as rabbit polyclonal
antibodies to human histones H2 and H4 and antibodies to hen egg white lysozyme
(HEWL) as the primary antibodies. Goat anti‐rabbit IgG was the secondary antibody
used. No reactivity with any shark protein was noted with anti‐histone antibodies
indicating (a) lack of reactivity with the heterologous antibody or absence of histone
fragment from lysates prepared by sonication. However, when primary antibody to
HEWL was used against the same pool, reactivity was seen with a protein band in shark
lysate that corresponds to the HEWL reactive control band (intensely stained in Figure
22), strongly suggesting the presence of lysozyme in shark leukocyte lysates.
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V. DISCUSSION

An integral function of innate immunity in all vertebrates is to protect the host
against microbial invasion. Protection is achieved, in part, by the antimicrobial action of
a variety of proteins (including enzymes) and peptides associated with body fluids (e.g.,
tears, saliva, mucus) and specialized cells in peripheral blood and tissues (e.g., cells
lining the gut wall). While much is known of the antimicrobial proteins/peptides of
mammals, amphibians and bony fish, relatively little information is available on
antimicrobials of sharks particularly those associated with peripheral blood leukocytes.
The specific aim of this study was to characterize antimicrobial proteins/peptides
associated with shark blood leukocytes.
The composition of nurse shark peripheral blood differs significantly from that of
teleosts (bony fish) and other vertebrates, particularly, humans. It is important to note
that shark plasma contains 0.25M NaCl and 0.35M urea. The high concentration of urea
in blood allows these animals to stay in osmotic balance. The high concentration of salt
and urea in circulating blood has to be taken into account when developing protocols
for processing serum/plasma and/or blood cells. Consequently, methods routinely used
in human or mouse research have to be modified by extensive trial and error work on
the bench. Staining of peripheral blood smears to obtain differential counts, poses a
challenge since most staining reactions depend on acidic and basic reactions of cells.
Furthermore, shark erythrocytes are nucleated (unlike that of humans), thus when
blood cells undergo lysis (induced or otherwise) considerable quantities of nucleic acid

84

released from erythrocytes is present in cell lysates. The presence of nucleic acid can be
a hindrance when attempting to isolate proteins/peptides from leukocyte lysates.
Several cell types found in shark peripheral blood are morphologically similar to
mammalian cells, although corresponding functional definition for all types remains
undetermined. Two types of granulocytic leukocytes are seen, one with deeply staining
prominent eosinophilic granules similar in morphology to the mammalian eosinophil,
the other with finer neutrophilic granules along with a bi‐ or tri‐lobed nucleus. Ultra‐
structural studies have shown the shark eosinophil to contain crystalline material within
the granules while the shark neutrophil granules are fibrous in nature (Stokes et al.
1971; Hyder et al. 1983; Smith et al. 1989). The proportion of eosinophilic leukocytes in
shark blood is considerably higher (11.5%) than that seen in human peripheral blood
(2.7%). This, in part can be an indication of a cellular immune response to parasites
which are harbored by sharks (Borucinska et al. 1993). Functional studies have shown
the shark neutrophil and monocyte‐macrophage to be phagocytic, similar to their
mammalian counterparts (Hyder et al. 1983; Smith et al. 1989). These two cell types
have also been shown to chemotactically (i.e., directional migration) respond to
appropriate stimuli (Obenauf et al. 1985; Smith et al. 1989). Some studies have shown
in certain shark species, the shark thrombocyte to also be phagocytic (Yokoyama 1960;
Fange 1968; Stokes et al. 1971; Ferguson 1976). The spindle shaped thrombocyte is a
cell type not found in mammalian blood, and thrombocytes may have an important role
in coagulation corresponding to the role of mammalian platelets (Gardner et al. 1969;
Stokes et al. 1971; Wardle 1971). In addition to the mononuclear lymphocytes seen in
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peripheral blood, immature, undifferentiated blast‐like cells are also occasionally seen.
The presence of blast‐like cells in peripheral blood is not surprising since sharks with
their cartilaginous skeleton do not have bone marrow, the site in mammals where
leukocyte maturation and differentiation occurs. In sharks, the site of hematopoiesis
(i.e., formation of erythrocytes and leukocytes) is the epigonal organ (a part of its
reproductive system), a lymphoid organ, and the spleen (Fange 1977; Fange et al. 1981;
Zapata 1981). Since cell lysates prepared from shark peripheral blood leukocytes show
significant antibacterial activity, it is reasonable to assume that the factors responsible
for this activity are most likely associated with the shark neutrophil and/or eosinophil as
well as the monocyte‐macrophage, an active phagocytic cell.
A variety of antimicrobial factors, include enzymes such as lysozyme (Petit et al.
1963; Jolles 1967), cathepsin G (Senior et al. 1982; Spitznagel 1990), phospholipase A2
(Dennis 1997), transferrin (Putnam 1975), and antibacterial proteins/peptides (e.g.
defensins, magainins, cecropins and cathelicidins) (Boman 1991). As stated above these
factors can be found in body fluids (e.g., saliva), mucus produced by the skin (e.g., frogs)
and contained within intracellular cytoplasmic granules.
In mammalian granulocytic cells, antibacterial proteins/peptides and enzymes (e.g.,
lysozyme) are normally found sequestered within intra‐cellular granules. My study has
shown that cell lysates prepared from nurse shark peripheral blood leukocytes are
antibacterial and inhibit the growth of Planococcus citreus, a salt tolerant bacterium.
Since shark leukocyte lysates also contained lysozyme activity, it is likely that lysozyme is
sequestered within intra‐cytoplasmic inclusions (lysosomes) of one or more cell type,
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most probably the phagocytic leukocytes. Lysozyme activity was detected in several
lysate preparations and was distinct from the non‐lysozyme antibacterial activity, the
isolation and characterization of which was the focus of this study. Initial screening of
lysates for lysozyme was accomplished using lysoplates (Osserman et al. 1966;
Manchenko 1994) and enzyme activity was estimated from the size of the zones of lysis
(clearing) of Micrococcus lysodeikticus. Chromatographic fractionation of crude lysates
revealed lysozyme activity to be present in early and late fractions recovered from
columns suggesting there might by two lysozyme molecules differing perhaps in one or
more amino acid residues. Slight differences in primary structure can result in
difference in over‐all protein charge which would account for the difference in binding
strength to the column. A protein corresponding to lysozyme was detected by Western
blotting in active fractions. The presence of shark lysozyme in lysate was confirmed by
amino acid sequence analysis of a 14 kDa protein separated by SDS‐PAGE. The presence
of multiple isoforms of lysozyme from the same organism or even the same biological
sample has been shown to be the case in the skin mucosa of rainbow trout (Fernandes
et al. 2004), the mantle of the pacific oyster (Itoh et al. 2010), and several other
invertebrate species (Cancado et al. 2008; Ursic‐Bedoya et al. 2008).
A microdilution growth assay was developed in order to achieve greater sensitivity
and a method for quantifying the level of antibacterial activity which was expressed as
percent inhibition of normal uninhibited bacterial growth. The assay, once
standardized, was able to detect levels of antibacterial activity as low as 5% inhibition in
titrated crude lysates. This assay proved to be reliable and reproducible and worked
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over a fairly broad range of pH and salinity. The density of the target organism did,
however, affect the detection sensitivity of the assay. With high bacterial densities the
antibacterial activity of lysates was masked since growth inhibition could not be
detected spectrophotometrically. A target cell density of 2.5 x 104cfu/ml was
determined to be optimal. Planococcus citreus, the target organism routinely used,
grows over a relatively wide temperature range, 27° to 37 °C, with an optimal
temperature of 30°C. The microdilution growth assay is now available and optimized for
future studies.
The protein concentration of crude lysates, prepared by sonication, ranged from 2 to
8 mg/ml depending on the quantity of leukocytes (8 x 108 ‐ 1 x 10 9 cells) harvested from
whole blood. The level of antibacterial activity of crude lysates correlated to the protein
concentration of the preparation. Although all lysates prepared showed antibacterial
activity, when titrated the level was low for some samples (activity was undetectable
following a 2‐fold dilution) while in others activity was 16‐fold or higher. Individual
variation from animal to animal could account for the variation in activity level.
Variation could be as a result of the time or temperature that the blood was collected,
or the age or gender of the shark, or even the size of the shark. As blood collection was
subject to all these conditions, it is difficult to ascribe a pattern or even control for these
variations, given that several different sharks were used in the course of this study.
Initially, crude lysates were used as starting material for chromatographic separation
of antibacterial activity. However, the recovery of activity in the active fractions was
low. To improve recovery and increase yield crude lysates were subjected to solid phase
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extraction as an initial first step in the isolation protocol. While activity was
concentrated by this procedure it was present in a fraction that also contained the bulk
of cellular protein and thus did not offer a significant advantage over lyophilization, a
less harsh method to obtain concentrated starting material. Ion exchange
chromatography of crude lysates concentrated by lyophilization resulted in recovery of
significant yield (measured in activity units). Anion exchange chromatography of
lysates was effective in separating lysozyme from non‐lysozyme antibacterial activity.
Initial fractionation of leukocyte lysates yielded several peptides in column fractions
which were visualized by SDS‐PAGE analysis and identified by N‐terminal amino acid
sequence analysis to have sequence homology to histone fragments. A variety of
histone fragments have been shown to be antibacterial in other vertebrate species
(Hiemstra et al. 1993; Robinette et al. 1998; Agerberth et al. 2000; Kawasaki et al. 2003;
Patat et al. 2004; Silphaduang et al. 2006).
Several investigators have used more sophisticated methods of chromatography,
such as HPLC and reverse phase HPLC, to isolate and purify antimicrobial
proteins/peptides (AMPs) from biological samples; however, I found that employing a
combination of one or more low pressure chromatography steps is sufficient to isolate
the antibacterial activity from the crude cell lysates, and to further separate the active
protein(s) from lysozyme, also present in lysates. Although the active protein/peptide(s)
were not purified to homogeneity using this simple protocol, it was sufficient to
separate the bulk of non‐antibacterial material contained in lysates, and to yield a
relatively “clean” preparation that contained two to four proteins (seen as distinct
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bands) that could be easily distinguished on coomassie blue stained gels after SDS‐PAGE
analysis. Furthermore, the antibacterial activity of each protein could be visualized by
zones of inhibition on bacterial lawns following transfer of proteins separated by acid
urea gel analysis. Consequently, the position of growth inhibition zones on the bacterial
lawn could be correlated to individual protein bands present on tandem run gels.
No immunoreactivity was obtained using antibodies to human histones. Therefore,
the presence of histones could not be confirmed since no reactivity was noted on the
blots. The lack of reaction could be due to (1) the antibodies not recognizing epitopes in
nurse shark histone fragments or (2) the concentration of primary and secondary
antibodies was not sufficient to get a reaction.
The presence of histone fragments isolated from peripheral blood leukocytes of the
nurse shark exhibiting antimicrobial activity has never been shown. These histone
fragments, identified by N‐terminal sequencing as histones H2A, H2B and H4 (identified
in a previous study (Hinds et al. 2001)) have been shown in the literature to be
antimicrobial in nature (as mentioned above) and isolated from a wide range of
organisms, especially aquatic organisms such as teleosts (Park et al. 1998; Birkemo et al.
2003; Fernandes et al. 2004; De Zoysa et al. 2009), bivalves (Li et al. 2007) and shrimp
(Patat et al. 2004). Table 7 lists the histone fragments that have been identified by N‐
terminal amino acid sequence analysis in shark leukocyte lysates and their homology to
other known antibacterial peptides identified in other species.
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Table 7 Alignment of Amino Acid Sequence of Shark Histone Fragments
Histone
Fragment
H2A

H2B

H4

Source

Sequence

Reference

Nurse Shark H2A‐1
Nurse Shark H2A‐2
Toad stomach tissue
(Buforin)
Catfish (Parasin I)
Pacific white shrimp
hemocyte
Rainbow trout skin
secretions
Nurse Shark H2B‐1
American oyster
Nurse Shark H2B‐2
Human
Channel catfish
Atlantic cod mucus
Pacific white shrimp
hemocyte
Nurse Shark H4‐1
Fruit fly*
Pacific white shrimp
hemocyte
Nurse Shark H4‐ 2
Fruit fly *

SRSERAGLQFQK
SIAISRSYRAGLQF
AGRGKQGGKVRAKAKTRSSRAGLQFPVG//
KGRGKQGGKVRAKAKTRSS
SGRGKGGKVKGKSSRSSRAGLQFPVGRI//

Present study
Present study
(Fernandes et al.
2002)
(Park et al. 1996)
(Park et al. 1998)

AERVGAGAPVYL

(Patat et al. 2004)

ESYSIYIYK
ESYAIYIYK
KGAK KRSRKEXY
KAQKKDSKKR KRSRKESYSVYVYK//

Present study
(Robinette et al. 1998)
Present study
(Frohm et al. 1996)
(Bergsson et al. 2005)
(Patat et al. 2004)
(Seo et al. 2010)

PDPAKTAPKKGSKKAVTKXA
PEVAKPAAKKGSKKAVSKVA//
AKHAVSEGTKAVT
DNIQLITKPAIRQLARR
KVLRDNIQGITKPAIRRLARRGGVK//
RDNIQGITKPAIRRL
RQGRTLYGFX
LKRQGRTLYGFGG

Present study
(Patat et al. 2004)

Present study

Note: Sequences are provided when available with references and sources with asterisk (*) are from
deduced amino acid sequences not yet proven to be antibacterial, and obtained through BLAST
searches.

Histones have long been known to have antibacterial activity (Hirsch 1958),
however, it was not known how they would interact with bacteria in the event of an
infection. It was almost 40 years later that Frohm et al (1996) suggested that histones
were responsible for wound healing when they isolated histone fragments from human
wound and blister fluid. Since then it has become clear that histones or histone
fragments are not only present in the nucleus of various organisms, but also in the
extra‐nuclear region where they can be exposed to intracellular pathogens. The
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discovery of neutrophil extracellular traps (NETs) (Brinkmann et al. 2004) has added to
this theory of extra‐nuclear histones, even expanding to the possibility that histones
work in conjunction with these nets together to trap and kill invading pathogens
(Brinkmann et al. 2004; Papayannopoulos et al. 2009). Histones because of their DNA
and RNA binding capabilities may work differently in killing bacteria than other
traditional antimicrobial peptides. Buforin II, a histone H2A fragment, has been shown
to penetrate through the cell membrane and to accumulate inside bacterial cell, leading
to the theory that it may inhibit cellular function by binding to nucleic acid (Park et al.
2000). It is therefore not outside the realm of possibilities that the nurse shark H2A
fragment which has high homology to buforin, could work in a similar manner. Histone
fragments were not identified in shark lysates prepared by sonication indicating that the
method of choice for preparing lysates does appear to determine the composition of
cellular proteins that will be recovered including those that are antibacterial.
Amino acid sequence analysis also generated some unexpected findings. Two very
similar hemoglobin fragments, as well as the protein ubiquitin, were isolated from
active chromatographic pools. These two protein fragments are known for having other
functions. Hemoglobin is a protein that transports oxygen (Altman et al. 1961) in
erythrocytes. Ubiquitin is a protein found everywhere in the cell, thus its name.
Ubiquitin’s main function is to covalently bind to proteins to act as a tag, and to shuttle
the tagged protein to the proteasome for degradation, thereby playing a role in MHC
Class I antigen presentation, as well as in vertebrate immune response via cytotoxic T
cells (Kindt et al. 2007). Hemoglobin from various species, in its intact form, as well as
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fragmented, (Parish et al. 2001; Nakajima et al. 2003) has been shown to be
antibacterial. Ubiquitin, on its own has not been shown to be antibacterial. However, it
has been associated, i.e. covalently bound, to histones (e.g. histone H1), which itself was
antibacterial (Wang et al. 2002). In addition, ubiquicidin, a protein with high homology
to a precursor of ubiquitin, has also been shown to be antibacterial (Hiemstra et al.
1999).
This study has revealed that shark leukocyte lysates contain several antibacterial
proteins/peptides, several of which show homology to antibacterial proteins described
for species of different phyla, indicating conservation of form and function through
evolution. This premise is particularly true for a protein such as lysozyme. Sequence
analysis also identified proteins with no known homology and which could very well be
unique to the shark. The elucidation of the mechanism of antibacterial activity of lysate
proteins/peptides was beyond the scope of this study, and remains a future goal. It is
clear from the data presented that several antibacterial proteins/peptides associated
with non‐oxidative antibacterial activity of mammalian leukocytes are also found in the
nurse shark, a primitive vertebrate. With this theory in mind, it could be said that shark
antibacterial proteins/peptides, play a significant role in the shark’s resilience to
infection and disease and its longevity.
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APPENDIX I

1.0

Preparation of Buffers, Stock Solutions and Media

Buffers and stock solutions were filtered through a 0.45 micron Nalgene filter before
use. Unless otherwise stated, all sterilization of liquids and culture media was carried
out in an autoclave at 121C for 20 min under 15 lbs. pressure. Autoclaved material was
cooled to room temperature before storage at 4C or stored at room temperature (RT).
Solutions were prepared as follows:
0.5 M sodium phosphate (Na H2 PO4)‐acidic solution:


34.5g Na H2 PO4, dry weight (Sigma, MO) was added to sterile deionized distilled
(dd) water (H2O) and the volume brought up to 500 ml.

0.5 M sodium phosphate (Na2 HPO4)‐basic solution:


35.5g Na2 HPO4, dry weight (Sigma, MO) was added to sterile ddH2O and the
volume brought up to 500 ml until salt completely dissolved.

Stock 0.5 M sodium phosphate (PB), pH 7.5


0.5 M sodium phosphate buffer of pH 7.5 was prepared by mixing appropriate
volumes of 0.5 M acid and base sodium phosphate stock solutions. To attain a
pH of 7.5, 95 ml of the acid was added to approximately 500 ml of the base.

Phosphate buffered saline (0.005M NaPO4, 0.14 M NaCl, pH 7.3)


2 g NaCl (Fisher Scientific, GA) was added to 0.005M PB (diluted 1:100 from
stock), and the mixture stirred until completely dissolved. The pH was adjusted
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to 7.3 with 1N HCl (approximately 5 drops). The final volume was adjusted to 250
ml with the diluted PB. The buffer was then sterilized.
Shark phosphate buffered saline (0.05 M NaPO4, 0.35M urea, 0.2 M NaCl, pH 7.3)


1.17 g NaCl (Fisher Scientific, GA) and 2.1g urea (Fisher Scientific, GA) was added
to 0.5 M PB (diluted 1:10 from stock) and the mixture stirred until completely
dissolved. The pH was adjusted to 7.3 with 1N HCl and the final volume was
adjusted to 100 ml with the diluted PB before sterilization.

Shark RPMI medium (RPMI 1640 containing 0.35M urea, 0.2 M NaCl)


This isotonic medium for shark blood cells was prepared by dissolving 3.5 g NaCl
and 6.3g urea (Fisher Scientific, GA) in 300 ml RPMI 1640 medium (Gibco/
Invitrogen, CA), containing 0.025 M Hepes Buffer with L‐glutamine, 0.1 micron
filtered, pH 7.3. The medium was further sterilized by filtration through 0.45
micron Nalgene filter and stored at 4C.

0.25M NaCl solution


An isotonic salt solution was used for suspending shark leukocytes and was
prepared by dissolving 3.65 g of NaCl in 250 ml of ddH2O and sterilized.

3.2% NaCl solution


This solution was used for washing salt tolerant bacterial stock culture and was
prepared by dissolving 3.2 g of NaCl in 100 ml of ddH2O and sterilizing.
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0.2% NaCl solution


This hypotonic solution was used to lyse contaminating erythrocytes present in
shark leukocytes isolated from whole blood, and was prepared by dissolving 0.2
g of NaCl in 100 ml of ddH2O and sterilizing.

2.5% NaCl solution


This hypertonic solution was used to neutralize the hypotonic salt solution
during lysis of RBC’s in shark leukocyte suspensions and was prepared by
dissolving 2.5 g of NaCl in 100 ml of ddH2O and sterilizing.

0.06 M phosphate buffer (0.06M NaPO4, variable pH)


60 ml 0.5 M phosphate stock buffer (PB) was diluted in 400 ml ddH2O and then
the pH was adjusted, using 1N NaOH/1N HCl .The volume was brought up to 500
ml before sterilization.

0.06 M phosphate buffer‐NaCl (0.06M NaPO4, 0.14M NaCl, variable pH)


0.818g NaCl was diluted in 80 ml of 0.06M PB and then the pH was adjusted
using 1N NaOH/1N HCl .The volume was brought up to 100 ml before
sterilization.

Artificial sea water salt solution 5x stock (2.585M NaCl, 0.125M MgSO4, 0.125M MgCl2,
0.05 M KCl, pH 7.5)


151.06g NaCl, 15.05g MgSO4 , 25.41g MgCl2 , and 3.73g KCl (Sigma, MO) were
added to ddH2O, and after the pH was adjusted to 7.5, using 1N NaOH/1N HCl,
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the volume brought up to 1000 ml. The stock solution was diluted five‐fold to
obtain a 1x working solution used to prepare media.

2.0

Staining Solutions

Modified Coomassie stain (23.47% methanol, 13% formaldehyde), used for staining
radial diffusion assay plates, was prepared by,


10 mg Coomassie Blue R‐250 dye (Sigma, MO) was dissolved in 63 ml ddH2O,
27 ml methanol (Fisher Scientific, GA) and 15 ml 37 % formaldehyde (Sigma, MO)
to give a total volume of 115 ml. The solution was stored in a dark bottle at
room temperature.

Modified Coomassie destain (10% acetic acid, 2% dimethylsulfonate‐DMSO)


50 ml glacial acetic acid (Fisher Scientific, GA) and 10 ml DMSO (Sigma, MO) was
added to 440 ml ddH2O and stored at room temperature.

Laemmli Coomassie stain for staining SDS‐PAGE gels.


1.875 g Coomassie Blue R‐250 dye (Sigma, MO) was dissolved in a mixture of 227
ml methanol (Fisher Scientific, GA) and 94 ml glacial acetic acid (Sigma, MO) and
the volume adjusted with 179 ml ddH2O. The solution was stored at room
temperature.
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Modified Laemmli Coomassie destain for SDS‐PAGE gels.


100 ml glacial acetic acid (Fisher Scientific, GA), 375 ml methanol (Sigma, MO)
and 25 ml glycerol (Sigma, MO) was added to 500 ml ddH2O for a total volume
of 1000 ml and stored at room temperature.

Modified Coomassie stain for staining PVDF membranes.


0.02g Coomassie Blue R‐250 dye (Sigma, MO) was dissolved in a mixture of 40 ml
methanol (Fisher Scientific, GA) and 60 ml ddH2O. The solution was stored at
room temperature.

3.0

Electrophoresis Solutions and Buffers

Electrophoresis 10X stock buffer (Oxford formula)


30g Tris and 144g glycine (Bio‐Rad, CA) was dissolved in 900 ml ddH2O, the pH
was adjusted to 8.8 with 1N NaOH/1N HCl and the total volume was adjusted to
1000 ml with ddH2O. The solution was filter sterilized (0.4 micron), and stored at
4°C.

Electrophoresis 1X running buffer‐SDS


10 ml 10% SDS ((Sigma, MO) was added to 100 ml 10X Electrophoresis buffer
diluted in 700 ml ddH2O. The pH was adjusted to 8.8 with 1N NaOH/1N HCl and
the total volume was brought up to 1000 ml.
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Sample buffer for SDS‐PAGE (5X non‐reducing)


0.6 ml 1M Tris‐HCl, pH 6.8, 5 ml 50% glycerol (Sigma, MO) in ddH2O, 2 ml 10%
SDS and 1 ml 1% bromophenol blue in ddH2O was added to 1.4 ml ddH2, and
filter sterilized (0.4 micron), and stored at ‐20°C.

Sample buffer for SDS‐PAGE (5X reducing)


0.6 ml 1M Tris‐HCl, pH 6.8, 5 ml 50% glycerol in ddH2O, 2 ml 10% SDS, 0.5 ml 2‐
mercaptoethanol (Sigma, MO) and 1 ml 1% bromophenol blue (Sigma, MO) in
ddH2O was added to 0.9 ml ddH2O,filter sterilized (0.4 micron), and stored at ‐
20°C.

30% acrylamide and 0.8% bis‐acrylamide


30 g acrylamide and 0.8 g bis‐acrylamide (Sigma, MO) were very carefully added to
100 ml ddH2O and mixed. The solution was stored in a dark bottle at 4 °C.

60% acrylamide and 1.6% bis‐acrylamide


60 g acrylamide and 1.6 g bis‐acrylamide (Sigma, MO) were very carefully added to
100 ml ddH2O and mixed. The solution was stored in a dark bottle at 4 °C.

Resolving buffer‐ 1.5M Tris‐HCl (pH 8.8)


75 ml 2 M Tris‐HCl, pH 8.8 (Fisher Scientific, GA) and 4ml 10% SDS were added
to 21 ml ddH2O, and mixed. The solution was stored at room temperature.

Stacking buffer‐ 0.5 M Tris‐HCl (pH 6.8)


50 ml 1M Tris‐HCl (pH 6.8) and 4ml 10% SDS were added to 46 ml ddH2O, and
mixed. The solution was stored at room temperature
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Acid‐urea electrophoresis buffer‐5% acetic acid


50 ml glacial acetic acid (Sigma, MO) was added to 950 ml ddH2O. The solution
was filter sterilized (0.4 micron) and stored at 4°C.

Acid‐urea sample buffer‐9M urea in 5% acetic acid


2.7 g urea was added to 2 ml ddH2O and mixed until dissolved. The solution was
then mixed with AG501‐X8 resin (Bio‐Rad, CA) to deionize for 20 min. The
solution was decanted , 0.25 ml glacial acetic acid was added and the volume
was adjusted to 5 ml final volume with ddH2O. 0.1g methyl green was added to
the final solution, which was filter sterilized (0.4 micron) and stored at ‐20°C.

Acid‐urea gel wash buffer‐0.01 M NaPO4, pH 7.5


10 ml 0.5 M Phosphate stock buffer (PB) was diluted in 490 ml ddH2O and then
the pH was adjusted, using 1N NaOH/1N HCl. The buffer was then sterilized.

4.0

Chromatography Buffers

For ion exchange chromatography, the following buffers were employed:
Equilibration buffer: 0.02 M Tris‐HCl, 0.05 M NaCl, pH 7.5


1.57 g Tris‐HCl was added to 400 ml ddH2O and the pH was adjusted to 7.5 with
1N NaOH. The final volume was adjusted to 500 ml with ddH2O and the buffer
filter sterilized.
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Elution buffer A: 0.02 M Tris‐HCl, 0.5 M NaCl, pH 7.5


11.69g NaCl was added to 400 ml 0.02 M Tris‐HCl, the pH adjusted to 7.5 with 1N
NaOH and the final volume adjusted to 500 ml with ddH2O before the buffer was
filter sterilized.

Elution buffer B: 0.02 M Tris‐HCl, 1.0M NaCl, pH 7.5


11.69g NaCl was added to 200 ml of 0.02 M Tris‐HCl, the pH was adjusted to 7.5
with 1N NaOH and the final volume adjusted to 250 ml with ddH2O before the
buffer was filter sterilized.

For heparin affinity chromatography, the following buffers were employed:
Equilibration buffer: 0.1 M Tris, 0.01 M Citric acid, 0.075M NaCl, pH 7.5


12.11 g Trizma base (Sigma, MO), 1.47 g citric acid (Fisher Scientific, GA) and
2.191 g NaCl was added to 400 ml ddH2O and the pH was adjusted to 7.5 with 1N
NaOH. The final volume was adjusted to 500 ml with ddH2O and the buffer filter
sterilized.

Elution buffer: 0.1 M Tris, 0.01 M citric acid, 2 M NaCl, pH 7.5


12.11 g Trizma base (Sigma, MO), 1.47 g citric acid (Fisher Scientific, GA) and
58.44 g NaCl was added to 400 ml ddH2O and the pH was adjusted to 7.5 with
1N NaOH. The final volume was adjusted to 500 ml with ddH2O and the buffer
filter sterilized.
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5.0

Culture Media

Double‐strength Artificial Sea Water Complete Broth (2x SCM), pH 7.5


5g peptone, 1g yeast extract, 3 ml glycerol, and 0.2g glycerol phosphate were
added to 400 ml of single strength artificial sea water salt solution (see above),
and the mixture stirred and heated until dissolved. The pH was adjusted to 7.5
with 1N NaOH and the volume made up to 500 ml. The broth was aliquoted (250
ml) to screw cap conical flasks, sterilized and stored at 4C.

Artificial Sea Water Complete Broth (1x SCM), pH 7.5


5g peptone, 1g yeast extract (Difco, MI), 3 ml glycerol, and 0.2g glycerol
phosphate (Sigma, MO) was dissolved in 1x artificial sea water salt solution (5
fold diluted stock) solution. The pH was adjusted to 7.5 with 10 N NaOH, and the
volume brought up to 1000 ml with 1x artificial sea water. Aliquots (50 ml) were
sterilized in 125 ml screw cap conical flasks and stored at 4C.

1% agar underlay with 0.02% Tween 20 for agar diffusion assay


2 g dehydrated agarose (Sigma, MO) was dissolved in 200 ml of 0.005 M PBS, pH
7.5, by heating the mixture. 20 l Tween 20 (Bio‐Rad, CA) was added to the
mixture and the agar sterilized, cooled to 44C in a water bath and dispensed as
10 ml aliquots into sterile 20 ml screw cap tubes and stored at 25C (room
temperature).
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1% agar overlay with SCM


2 g dehydrated agarose (Sigma, MO) was added to 2x artificial sea water
complete broth, and the mixture heated to dissolve the agar which was
sterilized and cooled to 44C in a water bath. The agar medium was dispensed
as 10 ml aliquots into sterile 20 ml screw cap tubes which were stored at 25C
(room temperature).

2% agarose in 0.06M PB, pH 6.2


4 g dehydrated agarose was dissolved in 200 ml of 0.06M PB, pH 6.2, by heating
and sterilized before dispensing as aliquots (100 ml) to 125 ml screw cap conical
flasks. Used in the preparation of lysoplates.

Tryptic Soy Broth


30 g dehydrated tryptic soy broth powder (Difco, MI) was suspended in 1 L
ddH2O and warmed slightly to dissolve. The broth was aliquoted (50 ml) to screw
cap conical flasks, sterilized and stored at room temperature.

Tryptic Soy Agar


40 g dehydrated tryptic soy agar powder (Difco, MI) was suspended in 1 L ddH2O
and warmed slightly to dissolve. The broth was aliquoted (15 ml) to screw cap
conical flasks, sterilized and stored as slants at room temperature.
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6.0

Reagents

3.8% Trisodium citrate (anticoagulant)


1.9g trisodium citrate (Sigma, MO) was dissolved in 50 ml shark RPMI, pH 7.3‐
7.5, and filter sterilized with a 0.45 micron Nalgene filter.

Human Neutrophil Peptide 1, HNP1


Lyophilized pellet (Sigma, MO) reconstituted to 25ug/ml in sterile ddH2O. This
served as an antibacterial control in antibacterial assays.

Chicken egg white lysozyme


A 1 mg/ml stock solution of chicken egg white lysozyme (muramidase) EC
3.2.1.17 (Sigma, MO) was prepared in ddH2O, and diluted 1:100 (final
concentration: 0.01 mg/ml) to use as a positive control in lysozyme assay plates
(lysoplates).

Cell viability test reagent


An isotonic reagent for shark leukocytes consisting of 0.1% trypan blue in 0.25M
NaCl was prepared by dissolving 0.05 g trypan blue stain in 50 ml 0.25M NaCl.
The solution was filtered and stored in 1 ml aliquots at RT.

7.0

Polyacrylamide Gels

Native‐PAGE resolving gel (7.5%)


2.5 ml 30% acrylamide:0.8% bis‐acrylamide (Sigma, MO), 2.5 ml 1.5M Tris‐HCl,
pH 8.8 (Fisher Scientific, GA), 5 ml ddH2O, 50 µl 10% ammonium persulfate (Bio‐
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Rad, CA) and 10 µl TEMED (Bio‐Rad, CA) were gently swirled together until
mixed. This mixture was immediately pipetted into assembled gel cassettes (Bio‐
Rad, CA) and allowed to polymerize at room temperature for 1 h.
Native‐PAGE resolving gel (10%)


3.33 ml 30% acrylamide:0.8% bis‐acrylamide (Sigma, MO), 2.5 ml 1.5M Tris‐HCl,
pH 8.8 (Fisher Scientific, GA), 6.67 ml ddH2O, 50 µl 10% ammonium persulfate
(Bio‐Rad, CA) and 5 µl TEMED (Bio‐Rad, CA) were gently swirled together until
mixed. This mixture was immediately pipetted into assembled gel cassettes (Bio‐
Rad, CA) and allowed to polymerize at room temperature for 1 h.

Native‐PAGE stacking gel (5%)


0.67 ml 30% acrylamide:0.8% bis‐acrylamide (Sigma, MO), 1 ml 0.5 M Tris‐HCl,
pH 6.8 (Fisher Scientific, GA), 2.3 ml ddH2O, 30 µl 10% ammonium persulfate
(Bio‐Rad, CA) and 5 µl TEMED (Bio‐Rad, CA) were gently swirled together until
mixed. This mixture was immediately pipetted into assembled gel cassettes (Bio‐
Rad, CA) on top of resolving gel and allowed to polymerize with appropriate
sized combs at room temperature for 30 m Polymerized gels were stored at 4 °C
until ready to use.
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8.0

Acid‐Urea Gels

Acid‐urea gel (12.5%)


4.8 g urea (Fisher Scientific, GA) was mixed with 7.8ml ddH2O until dissolved,
then 3.34 ml 60% acrylamide:1.6% bis‐acrylamide (Sigma, MO), 0.87 ml glacial
acetic acid (Fisher Scientific, GA), 0.30 ml 10% APS (Bio‐Rad, CA) and 0.12 Ml
TEMED (Bio‐Rad, CA) were added and gently swirled until mixed. This mixture
was immediately pipetted into assembled gel cassettes (Bio‐Rad, CA) and
allowed to polymerize at 30°C with appropriate sized combs for up to 2 hours.
Polymerized gels were stored at 4 °C until ready to use.

9.0

Target Bacteria for antibacterial assays

The following bacterial cultures were used as target organisms in antibacterial assays:


Planococcus citreus (NCIMB 1493) was the target organism used in the
antibacterial assay s and was kindly provided by Dr. Valerie Smith, St. Andrews
University, Scotland. The organism has been shown to be a problem in
commercial shrimp culture implicated in shrimp spoilage (Alvarez et al. 1981).

10.0

Cell Walls for muramidase activity

The following cell wall preparation was used as target organism in lysozyme assays:


A lyophilized suspension of cell walls of Micrococcus lysodeikticus (ATCC 4698)

was used as the substrate for muramidase (lysozyme) activity in lysoplates.
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11.0

Western Blot Buffers and Reagents

Transfer buffer


100 ml 10X Electrophoresis buffer was diluted in 700 ml ddH2O. The pH was
adjusted to 8.8 with 1N NaOH/1N HCl and the total volume was brought up to
900 ml.



100 ml methanol was added to the buffer (to facilitate transfer of smaller
proteins) and mixed. The buffer was stored at 4 °C.

Blocking solution‐5% nonfat dried milk


A 5% nonfat dried milk solution was prepared by dissolving 50 g nonfat dried
milk (Carnation) in 1 L ddH2O. Fresh blocking solution was prepared each time.

Tris buffered saline (TBS)


11.69g NaCl was added to 400 ml 0.02 M Tris‐HCl and the pH adjusted to 7.5
with 1N NaOH, and the final volume adjusted to 500 ml with ddH2O before the
buffer was filter sterilized.

Wash diluent buffer‐1% milk in TBS with Tween 20


10 g nonfat dried milk was added to 1 L TBS and mixed until dissolved. 100 µl
Tween 20 (Bio‐Rad, CA) was added and solution stored at 4 °C.

Antibody buffer‐1% milk in TBS


1 g nonfat dried milk was added to 100 ml TBS and mixed until dissolved and
solution stored at 4 °C.
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Rabbit anti‐human H4 polyclonal antisera


Affinity‐purified rabbit anti‐acetyl‐histone H4 (Sigma, MO) antibody was diluted
1:750 in antibody buffer and stored at 4 °C.

Rabbit anti‐human HDAC4 (H4) polyclonal antisera


Affinity purified rabbit anti‐histone deacetylase 4 (Sigma, MO) antibody was
diluted 1:1000 in antibody buffer and stored at 4 °C.

Rabbit anti‐human HDAC2 (H2) polyclonal antisera


Affinity purified rabbit anti‐histone deacetylase 2 (Sigma, MO) antibody was
diluted 1:2000 in antibody buffer and stored at 4 °C.

Rabbit anti‐hen egg white lysozyme polyclonal antisera


Rabbit anti‐HEWL (Rockland, PA) was diluted 1:1000 in antibody buffer and
stored at 4 °C.

Peroxidase conjugated goat anti‐rabbit IgG antisera


Goat anti‐rabbit IgG (Rockland, PA) was diluted 1:1000 in antibody buffer and
stored at 4 °C.

Horseradish peroxidase (HRP) conjugate substrate kit


The kit (Bio‐Rad, CA) was assembled according to the manufacturer’s
instructions: 600 µl HRP color reagent B (containing hydrogen peroxide) was
added to 100 ml of 1x HRP color development buffer at RT. This solution was
added to 20 ml of HRP color reagent A (containing 4‐chloro‐1‐naphthol in
diethylene glycol) and reagent used immediately.
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